Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3042810	li-bam42	ng/l (ng/l)	1589	1620	0.49%
3042810	li-bam42	— (—)	739	755	100.00%	Distribution not available
3042810	li-beeta-amyloidi42proteiini,likvor	ng/l (ng/l)	5	5	0.00%	Distribution not available	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Dementia

1136

348

23.67

307.65

1.0

604.05

824.22

ng/l

14.24

819

201

Hydrocephalus

367

137

30.21

307.65

1.1

1.0

554.06

674.65

ng/l

2.33

114

Use of memantine

513

395

11.17

307.65

1.0

554.36

690.94

ng/l

6.33

358

221

Any dementia, excluding more controls

979

322

22.10

307.65

1.0

605.88

764.22

ng/l

7.54

723

182

Implicit Sepsis

1173

1000

8.76

307.65

1.0

779.26

712.89

ng/l

3.10

924

584

Other symptoms and signs involving cognitive functions and awareness

1394

483

27.81

307.65

1.0

757.81

701.18

ng/l

1.57

1121

242

Dementia, including avohilmo

1189

424

20.30

307.65

1.0

617.35

849.00

ng/l

16.95

857

244

Use of anticholinesterases

888

453

16.28

307.65

1.0

565.69

765.34

ng/l

14.96

644

263

Other degenerative diseases of the nervous system

951

145

52.14

307.65

1.0

620.08

843.03

ng/l

7.10

712

107

Alzheimer disease, including avohilmo

902

420

15.88

307.65

1.0

569.20

771.48

ng/l

13.29

650

238

Any mental disorder

968

720

6.81

307.65

1.0

691.55

846.98

ng/l

10.64

685

448

Alzheimer’s disease (Early onset)

243

70.62

307.65

1.0

532.54

796.00

ng/l

2.23

189

Unspecific neurodegenerative disorder

1067

416

18.43

307.65

1.0

585.75

808.85

ng/l

17.71

763

238

Organic, including symptomatic, mental disorders

1338

440

22.77

307.65

1.0

649.74

838.00

ng/l

12.81

950

262

Use of donepezil

520

353

14.89

307.65

1.0

544.11

702.70

ng/l

8.19

384

197

Alzheimer disease

793

391

15.58

307.65

1.0

561.00

736.02

ng/l

10.14

577

218

Any dementia

991

428

16.91

307.65

1.0

604.51

783.59

ng/l

11.84

730

240

Alzheimer’s disease, strict definition

696

314

19.30

307.65

1.0

556.79

740.28

ng/l

9.42

520

170

Normal-pressure hydrocephalus

342

47.03

307.65

1.1

1.0

555.11

612.32

ng/l

0.60

103

Psychiatric diseases

836

447

9.47

307.65

1.0

703.78

887.07

ng/l

9.56

586

289

Condition for Implicit Sepsis (Organ dysfunction codes)

1390

683

14.36

307.65

1.0

767.98

719.54

ng/l

1.46

1089

350

N06DA Anticholinesterases

888

453

16.28

307.65

1.0

565.69

765.34

ng/l

14.96

644

263

Symptoms and signs involving cognition, perception, emotional state and behaviour

1463

708

14.41

307.65

1.0

762.45

721.18

ng/l

1.14

1137

363

Alzheimer disease, excluding more controls

758

201.81

307.65

1.0

1.1

559.57

948.91

ng/l

3.95

560

Implicit Sepsis

949

1177

6.19

307.65

1.0

779.03

719.46

ng/l

2.61

748

728

Other mental disorders due to brain damage and dysfunction and to physical disease

402

123

35.51

307.65

1.0

764.34

828.80

ng/l

0.76

275

Use of other anti-dementia drugs

513

395

11.17

307.65

1.0

554.36

690.94

ng/l

6.33

358

221

Degenerative diseases of the nervous system

974

428

17.65

307.65

1.0

618.16

757.45

ng/l

7.56

722

248

Alzheimer’s disease (Late onset)

480

288

14.60

307.65

1.0

566.34

731.19

ng/l

6.83

344

155

Dementia in Alzheimer disease

322

122

23.11

307.65

1.0

539.15

734.19

ng/l

4.67

191

Condition for Implicit Sepsis (Organ dysfunction codes)

1345

800

12.15

307.65

1.0

770.21

718.47

ng/l

1.79

1061

425

Use of rivastigmine

321

288

11.64

306.50

1.0

571.20

651.51

ng/l

2.21

231

161

Depression or dysthymia

423

253

9.31

253.57

1.0

806.81

865.31

ng/l

0.85

283

163

Intracranial trauma

346

266

9.22

238.04

1.0

759.11

855.78

ng/l

1.88

217

195

Memory loss

177

19.74

226.73

1.0

704.11

853.09

ng/l

1.96

130

Mood disorders, excluding more controls

591

702

5.06

226.31

1.0

815.32

849.99

ng/l

0.69

412

441

Other neurological diseases

677

1361

3.96

214.75

1.0

725.88

737.02

ng/l

0.19

355

1019

Unspecified dementia

167

21.46

207.52

1.0

634.57

758.49

ng/l

1.36

129

Circumscribed brain atrophy

122

47.94

205.61

1.0

884.32

747.27

ng/l

0.83

Neurological diseases

438

327

6.77

199.64

1.0

722.36

851.89

ng/l

3.82

300

232

Concussion

270

266

8.34

187.30

1.0

771.62

855.78

ng/l

1.39

175

195

Implicit viral Sepsis

299

474

6.42

179.37

1.0

776.48

697.89

ng/l

1.70

222

279

Parkinson's disease, excluding more controls

113

37.34

174.20

1.0

1.1

615.48

1016.54

ng/l

3.63

Dizziness and giddiness

412

665

4.95

173.38

1.0

730.57

708.88

ng/l

0.32

257

337

Symptoms and signs involving the nervous and musculoskeletal systems

518

1345

3.90

173.24

1.0

761.61

719.49

ng/l

1.08

324

929

Parkinson's disease, strict definition, excluding more controls

101

34.92

154.20

1.0

1.1

626.01

979.78

ng/l

3.19

Implicit bacterial Sepsis

392

794

4.32

144.01

1.0

766.35

705.02

ng/l

1.68

302

467

Recurrent or chronic depression

202

153

9.35

140.56

1.0

858.63

857.26

ng/l

0.01

128

105

Other and unspecified degenerative diseases of nervous system

27.28

135.36

1.1

1.0

714.64

732.95

ng/l

0.07

Other antidepressants

656

1055

3.21

133.31

1.0

749.41

731.83

ng/l

0.36

437

738

Undefined dementia

167

182

8.67

125.58

1.0

634.57

640.37

ng/l

0.05

129

Alzheimer’s disease (Atypical or mixed)

126

105

12.23

125.14

1.0

1.1

594.14

723.00

ng/l

1.50

Delirium, not induced by alcohol and other psychoactive substances

126

108

11.90

123.65

1.0

654.32

816.10

ng/l

2.21

Implicit bacterial Sepsis

334

744

4.02

113.11

1.0

754.89

701.52

ng/l

1.24

255

442

Anxiety disorders, excluding more controls

375

641

3.83

107.50

1.0

837.67

853.88

ng/l

0.22

281

407

Other symptoms and signs involving the nervous and musculoskeletal systems

330

907

3.68

101.97

1.0

776.46

721.63

ng/l

1.15

210

630

Use of galantamine

130

158

8.53

99.61

1.1

1.0

589.40

632.64

ng/l

0.49

Vascular dementia

12.90

98.27

1.0

677.69

760.37

ng/l

0.63

Abnormalities of gait and mobility

164

262

6.44

98.19

1.0

670.65

662.14

ng/l

0.08

168

Bacterial Sepsis

337

821

3.54

94.41

1.0

752.46

705.47

ng/l

1.06

257

487

Viral Sepsis

187

351

5.41

94.34

1.1

1.0

771.26

688.57

ng/l

1.36

133

206

Implicit viral Sepsis

186

351

5.38

93.28

1.1

1.0

771.26

688.57

ng/l

1.36

133

206

Selective serotonin reuptake inhibitors

563

1055

2.80

92.68

1.0

765.73

731.83

ng/l

0.77

368

738

Schizophrenia or delusion, excluding more controls

159

263

6.03

90.20

1.0

797.50

853.77

ng/l

0.66

119

165

Dementia in other diseases classified elsewhere

16.37

86.74

1.0

703.11

756.07

ng/l

0.28

Traumatic subdural haemorrhage

10.41

80.38

1.0

607.91

850.53

ng/l

3.24

Medical observation and evaluation for suspected diseases and conditions

384

611

3.23

79.37

1.0

762.61

712.06

ng/l

0.97

228

455

Mood [affective] disorders

596

1612

2.41

78.26

1.0

816.24

727.91

ng/l

4.00

417

1113

Mood disorders

596

1616

2.40

77.54

1.0

816.95

726.74

ng/l

4.15

416

1118

Depression

543

1549

2.39

70.88

1.0

830.49

728.63

ng/l

4.65

374

1078

Substance abuse, excluding more controls

239

565

3.62

69.74

1.0

808.16

849.36

ng/l

0.62

169

365

Malaise and fatigue

341

964

2.87

66.83

1.0

734.46

724.85

ng/l

0.13

230

661

Vascular dementia (subcortical)

18.02

63.85

1.1

1.0

645.86

843.94

ng/l

1.11

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

133

6.98

62.41

1.0

797.71

697.93

ng/l

0.79

Extrapyramidal and movement disorders

285

971

2.97

62.38

1.0

726.09

713.49

ng/l

0.17

188

648

Nonorganic sleeping disorders, excluding more controls

129

7.19

62.07

1.0

869.29

851.02

ng/l

0.10

Other and unspecified hydrocephalus

16.95

61.21

1.1

1.0

579.21

612.70

ng/l

0.11

Neurological diseases, wide definition

101

9.09

56.67

1.0

723.09

906.68

ng/l

1.31

Injuries to the head

584

1704

2.12

56.20

1.0

762.31

742.69

ng/l

0.45

388

1186

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

102

181

5.64

54.37

1.0

793.34

847.38

ng/l

0.44

120

Postprocedural disorders of nervous system

8.98

54.10

1.0

789.38

760.77

ng/l

0.12

Psychotic depression

23.25

53.75

1.0

1.1

760.60

782.50

ng/l

0.06

Epilepsy

202

612

3.32

53.69

1.0

729.30

721.01

ng/l

0.08

146

419

Benzodiazepine use

535

1769

2.09

51.41

1.0

780.85

736.86

ng/l

1.25

369

1213

General examination and investigation of persons without complaint and reported diagnosis

320

611

2.75

51.26

1.0

826.57

712.06

ng/l

3.04

207

455

Personality disorders, excluding more controls

178

5.14

43.91

1.0

829.05

847.15

ng/l

0.12

116

Intracranial injury

317

1280

2.35

43.59

1.0

740.50

728.98

ng/l

0.16

193

862

Depression medications

126

133

4.79

42.59

1.0

811.26

701.98

ng/l

1.27

100

Convulsions, not elsewhere classified

146

415

3.50

42.26

1.0

714.49

758.51

ng/l

0.47

102

288

General symptoms and signs

504

1273

1.99

39.41

1.0

750.48

745.01

ng/l

0.09

340

896

Use of levodopa decarboxylase inhibitor

128

356

3.65

39.36

1.0

641.61

686.27

ng/l

0.55

225

Bipolar affective disorders

108

267

4.08

39.11

1.0

761.48

768.59

ng/l

0.06

197

Syncope and collapse

260

912

2.45

38.46

1.0

714.98

729.87

ng/l

0.21

162

621

Kela-code for severe mental illness

203

757

2.70

37.72

1.0

771.49

753.18

ng/l

0.22

146

524

Unspecified mental disorder

217

845

2.58

36.94

1.0

766.98

755.29

ng/l

0.14

157

583

Fall on same level

534

1558

1.88

36.19

1.0

747.43

754.54

ng/l

0.13

371

1092

Other special examinations and investigations of persons without complaint or reported diagnosis

288

611

2.39

35.29

1.0

793.22

712.06

ng/l

1.74

185

455

Persons encountering health services for examination and investigation

290

611

2.39

35.22

1.0

760.72

712.06

ng/l

0.83

191

455

Other extrapyramidal and movement disorders in other diseases

165

581

2.87

34.32

1.0

788.42

715.69

ng/l

1.03

110

396

Focal epilepsy

141

468

3.04

32.59

1.0

747.27

735.86

ng/l

0.10

100

311

Other symptoms and signs involving general sensations and perceptions

11.18

32.06

1.0

730.23

504.82

ng/l

1.63

Examination and observation for other reasons

249

611

2.37

31.05

1.0

742.75

712.06

ng/l

0.47

161

455

Focal epilepsy, mode (most common among epilepsy diagnosis)

127

414

3.10

30.34

1.0

732.47

743.85

ng/l

0.09

274

Other degenerative diseases of the basal ganglia

8.75

29.41

1.1

1.0

620.27

533.89

ng/l

0.53

Communicating hydrocephalus

9.82

29.02

1.2

1.0

460.18

557.05

ng/l

0.48

Focal epilepsy, strict definition

130

443

2.96

28.76

1.0

753.03

736.54

ng/l

0.14

294

Anxiety (asthma-related co-morbidities)

245

855

2.22

28.60

1.0

850.37

731.42

ng/l

3.40

184

607

Parkinson's disease, including avohilmo

126

428

2.98

28.12

1.0

636.60

699.74

ng/l

0.90

274

Non-selective monoamine reuptake inhibitors

184

736

2.42

27.33

1.0

870.39

723.54

ng/l

3.02

122

525

Implicit fungal Sepsis

110

5.18

27.13

1.0

875.09

559.68

ng/l

4.33

Other anxiety disorders

188

688

2.38

26.28

1.0

820.90

735.88

ng/l

1.62

139

484

Headache

282

1126

2.01

25.50

1.0

757.37

741.77

ng/l

0.21

189

794

Schizophrenia, schizotypal and delusional disorders

161

653

2.48

25.39

1.0

797.41

740.83

ng/l

0.85

120

454

Schizophrenia or delusion

159

648

2.47

24.82

1.0

797.50

742.29

ng/l

0.82

119

452

Cerebrovascular diseases

403

1594

1.78

24.79

1.0

753.06

728.37

ng/l

0.44

263

1097

Infections, IBD-co-morbidities

6.36

24.74

1.0

757.00

877.54

ng/l

0.68

Other disorders of urethra and urinary system

335

1288

1.88

24.70

1.0

734.20

725.08

ng/l

0.14

231

865

Hypothyroidism (congenital or acquired)

132

3.82

24.64

1.0

882.90

701.98

ng/l

1.97

100

Episodal and paroxysmal disorders

453

1317

1.75

24.59

1.0

760.24

720.78

ng/l

0.96

305

899

Other and unspecified nonorganic psychotic disorders

311

3.14

23.93

1.0

841.26

782.19

ng/l

0.53

212

Hypothyroidism and >3 levothyroxin purchases

131

3.77

23.67

1.0

883.12

701.98

ng/l

1.93

100

Hypothyroidism, levothyroxine purchases

131

3.77

23.67

1.0

883.12

701.98

ng/l

1.93

100

Progressive vascular leukoencephalopathy

6.37

22.80

1.1

1.0

635.50

605.18

ng/l

0.16

Parkinson's disease

113

407

2.81

22.76

1.0

615.48

701.04

ng/l

1.45

259

Constipation

428

1758

1.69

21.85

1.0

740.77

739.27

ng/l

0.02

296

1205

STROKE

316

1169

1.85

21.66

1.0

761.24

732.04

ng/l

0.50

219

820

Focal brain injury

7.56

21.21

1.0

883.77

922.10

ng/l

0.08

Manic episode

8.09

20.07

1.0

741.68

629.82

ng/l

0.39

All anxiety disorders

245

1004

1.93

20.05

1.0

850.37

741.20

ng/l

3.04

184

704

severe traumatic brain injury, does not include concussion

133

554

2.42

19.94

1.0

698.27

723.54

ng/l

0.24

366

Covid-19 confirmed case

181

859

2.12

19.82

1.1

1.0

695.82

725.46

ng/l

0.39

122

562

Disorders of thyroid, IBD co-morbidities

5.41

19.39

1.0

645.76

906.68

ng/l

1.99

Parkinson's disease, strict definition

101

375

2.72

19.27

1.0

626.01

692.40

ng/l

0.90

237

Open wound of head

247

1272

1.88

19.19

1.0

744.06

734.54

ng/l

0.12

166

871

Alcohol abuse, main dg, excluding more controls

136

3.92

18.44

1.0

1.1

799.36

843.09

ng/l

0.27

Abnormal involuntary movements

274

2.98

18.36

1.0

842.02

718.20

ng/l

1.31

184

Anxiety disorders

378

1594

1.66

18.06

1.0

839.77

739.14

ng/l

3.76

283

1093

Metabolic disorders

424

1603

1.62

17.99

1.0

759.98

747.87

ng/l

0.20

302

1087

Neurotic, stress-related and somatoform disorders

372

1575

1.66

17.80

1.0

844.00

738.24

ng/l

3.99

277

1082

Provisional assignment of new diseases of uncertain etiology

227

1218

1.87

17.48

1.1

1.0

714.61

728.52

ng/l

0.19

158

804

Codes for special purposes

227

1220

1.86

17.39

1.1

1.0

714.61

728.38

ng/l

0.18

158

805

Sequelae of injuries of head

105

4.26

16.96

1.0

798.76

759.59

ng/l

0.16

Care involving use of rehabilitation procedures

305

1665

1.69

16.53

1.0

787.42

741.37

ng/l

1.04

248

1120

Dorsalgia

391

1292

1.62

16.46

1.0

762.00

722.75

ng/l

0.87

244

919

Nonorganic sleeping disorders

354

2.61

16.39

1.0

869.29

759.43

ng/l

1.29

245

Other dorsopathies, not elsewhere classified

398

1292

1.62

16.31

1.0

752.87

722.75

ng/l

0.59

255

919

Superficial injury of head

111

470

2.37

16.13

1.0

760.91

725.98

ng/l

0.34

321

Other intervertebral disc disorders

352

1290

1.65

16.05

1.0

776.24

721.81

ng/l

1.19

235

918

Falls/tendency to fall

420

1328

1.59

15.86

1.0

760.31

753.10

ng/l

0.11

289

933

Lower back pain or/and sciatica

441

1869

1.54

15.66

1.0

777.40

740.95

ng/l

0.77

268

1318

Spondylopathies

351

1284

1.64

15.64

1.0

796.17

721.78

ng/l

1.93

218

915

Disorders of lipoprotein metabolism and other lipidaemias

399

1565

1.58

15.62

1.0

750.99

746.84

ng/l

0.06

293

1059

Schizoaffective disorder

130

3.73

15.57

1.0

835.03

756.38

ng/l

0.56

Monoamine oxidase A inhibitors

185

3.21

15.28

1.1

1.0

804.87

730.48

ng/l

0.46

138

Anaemias

131

3.25

15.27

1.0

777.80

701.98

ng/l

0.52

100

Cerebrovascular diseases (FINNGEN)

176

633

1.98

15.11

1.0

729.03

735.54

ng/l

0.07

128

465

Speech disturbances, not elsewhere classified

202

3.10

15.10

1.1

1.0

674.36

677.35

ng/l

0.02

119

Parasetamol

276

817

1.72

14.15

1.0

744.91

748.78

ng/l

0.04

185

614

Follow-up examination after treatment for conditions other than malignant neoplasms

154

504

2.03

14.07

1.0

781.48

697.48

ng/l

1.49

112

383

Pure hypercholesterolaemia

366

1525

1.57

14.07

1.0

720.86

745.11

ng/l

0.49

272

1030

Persons encountering health services for specific procedures and health care

435

1725

1.51

14.00

1.0

790.26

743.51

ng/l

1.31

321

1163

Other disorders of ear

413

1776

1.53

13.99

1.0

760.44

740.92

ng/l

0.36

276

1237

Generalized anxiety disorder

170

3.19

13.90

1.0

780.76

773.21

ng/l

0.04

116

Low back pain

294

1291

1.64

13.72

1.0

738.09

722.75

ng/l

0.22

182

919

Poisoning by medicine

369

2.42

13.64

1.0

837.38

768.27

ng/l

0.61

257

Sleep disorders (combined)

448

1568

1.50

13.51

1.0

776.20

717.79

ng/l

1.87

310

1062

Poisoning by drugs, medicaments and biological substances

417

2.31

13.26

1.0

825.01

758.69

ng/l

0.64

290

Shoulder lesions

348

1354

1.56

12.89

1.0

808.77

727.51

ng/l

2.30

232

927

Viral infections of the central nervous system

119

3.56

12.81

1.0

836.12

715.35

ng/l

0.60

Sequelae of cerebrovascular disease

174

817

1.84

12.74

1.0

733.66

703.58

ng/l

0.37

125

531

Malignant neoplasm of digestive organs

1086

0.36

12.48

1.0

692.71

714.37

ng/l

0.16

712

261

1413

1.63

12.43

1.0

782.29

744.60

ng/l

0.67

182

971

Other sleep disorders

226

2.76

12.40

1.0

813.97

734.83

ng/l

0.52

150

Factors influencing health status and contact with health services

123

286

2.16

12.40

1.0

755.52

687.48

ng/l

0.62

211

Sciatica+with lumbago

221

1202

1.70

12.33

1.0

834.09

725.74

ng/l

2.08

129

863

Other encephalitis

5.57

12.15

1.0

680.94

580.54

ng/l

0.40

Viral infections of the central nervous system

130

3.34

11.90

1.0

815.81

716.71

ng/l

0.47

Other diseases of urinary system

404

1529

1.49

11.89

1.0

735.02

738.39

ng/l

0.05

287

1040

Symptoms and signs involving speech and voice

155

840

1.85

11.85

1.0

761.47

721.23

ng/l

0.59

120

553

Viral encephalitis, not elsewhere classified/unspecified

5.97

11.85

1.0

694.17

606.25

ng/l

0.29

Lumbar disc prolapse

267

1275

1.61

11.84

1.0

784.17

722.05

ng/l

1.26

173

912

Dorsopathies

383

1293

1.51

11.78

1.0

781.12

722.75

ng/l

1.45

244

919

Statin medication

230

766

1.69

11.62

1.0

770.15

761.31

ng/l

0.10

158

543

Other headache syndromes

160

880

1.82

11.61

1.0

760.90

717.05

ng/l

0.59

101

607

Cerebral cysts

4.12

11.59

1.0

776.46

680.22

ng/l

0.45

248

1387

1.62

11.59

1.0

784.87

748.39

ng/l

0.62

175

952

Abnormal findings on diagnostic imaging of central nervous system

3.77

11.58

1.1

1.0

694.83

713.29

ng/l

0.08

Mental and behavioural disorders due to psychoactive substance use

248

1424

1.62

11.57

1.0

801.78

744.66

ng/l

1.25

177

984

Dysphagia

128

657

1.96

11.56

1.0

704.20

711.00

ng/l

0.06

421

Other reaction to severe stress, and adjustment disorders

127

651

1.96

11.49

1.0

906.11

739.29

ng/l

3.19

466

Fever of other and unknown origin

209

1105

1.69

11.43

1.0

776.47

737.19

ng/l

0.52

136

765

Conductive and sensorineural hearing loss

368

1668

1.49

11.39

1.0

767.25

733.44

ng/l

0.64

241

1150

Secondary parkinsonism+Parkinsonism in other disease

4.65

11.22

1.0

663.58

593.33

ng/l

0.21

Degeneration of the brain due to alcohol

5.65

11.22

1.0

1.1

712.40

637.72

ng/l

0.32

Somnolence, stupor and coma

5.58

11.18

1.0

1.1

659.86

603.08

ng/l

0.16

Other functional intestinal disorders

202

1113

1.69

11.16

1.0

773.86

712.37

ng/l

1.01

140

745

Symptoms and signs involving emotional state

12.84

11.15

1.0

672.46

442.83

ng/l

—

Behavioural syndromes associated with physiological disturbances and physical factors

354

1684

1.49

11.13

1.0

817.92

739.22

ng/l

2.28

242

1166

Mental and behavioural disorders due to alcohol

219

1281

1.65

11.08

1.0

803.12

747.16

ng/l

1.04

153

888

Non-invasive ventilation

103

442

2.09

10.95

1.1

1.0

725.56

669.77

ng/l

0.77

314

Pain in throat and chest

332

1316

1.52

10.94

1.0

789.28

724.51

ng/l

1.63

231

893

Persistent mood disorders

357

2.28

10.91

1.0

820.24

729.69

ng/l

1.01

249

Unspecified fall

209

1247

1.66

10.83

1.0

770.76

718.21

ng/l

0.77

143

831

Encephalitis

4.97

10.76

1.0

680.94

632.79

ng/l

0.16

Alcohol use disorder, Swedish definition

235

1342

1.61

10.76

1.0

785.73

748.94

ng/l

0.60

165

925

Other diseases of intestines

397

1551

1.46

10.66

1.0

792.85

737.17

ng/l

1.33

272

1069

Substance abuse

239

1412

1.59

10.58

1.0

808.16

744.16

ng/l

1.41

169

979

Symptoms and signs involving the urinary system

333

1710

1.49

10.40

1.0

746.96

739.53

ng/l

0.11

233

1149

Other external causes of accidental injury

305

994

1.54

10.36

1.0

748.01

749.74

ng/l

0.02

209

677

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

102

503

2.03

10.35

1.0

793.34

754.94

ng/l

0.33

359

Disorders of adult personality and behaviour

470

2.07

10.32

1.0

845.75

749.88

ng/l

1.26

339

Secondary parkinsonism

4.47

10.30

1.0

692.91

623.00

ng/l

0.20

Cervicalgia

451

2.09

10.28

1.0

785.08

689.54

ng/l

0.95

321

Persistent delusional disorders

164

2.89

10.27

1.0

705.94

729.59

ng/l

0.14

103

Spinal stenosis

240

1148

1.59

10.22

1.0

771.36

709.53

ng/l

1.13

146

811

Transient ischemic attack

246

1269

1.57

10.08

1.0

786.69

704.75

ng/l

1.64

163

834

Use of hypnotics and sedatives

429

1743

1.42

9.88

1.0

791.98

731.32

ng/l

1.85

302

1188

Hypotension

415

2.11

9.70

1.0

723.90

680.18

ng/l

0.43

261

Bleeding

360

1776

1.44

9.65

1.0

710.84

749.85

ng/l

0.89

225

1239

Sensorineural hearing loss

349

1632

1.45

9.63

1.0

767.76

728.23

ng/l

0.76

227

1121

Accidents

299

994

1.51

9.33

1.0

743.43

749.74

ng/l

0.08

206

677

Sleep disorders

331

1645

1.46

9.31

1.0

801.05

741.28

ng/l

1.44

227

1137

Suicide or other Intentional self-harm

487

1.98

9.07

1.0

793.23

755.10

ng/l

0.31

346

Vascular dementia (mixed)

10.21

9.06

1.0

1.1

611.40

731.10

ng/l

—

Other soft tissue disorders, not elsewhere classified

337

1361

1.45

9.06

1.0

805.32

726.73

ng/l

2.24

231

930

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

820

0.31

9.04

1.0

767.00

705.66

ng/l

0.23

531

Pain in limb

299

1360

1.47

8.84

1.0

833.40

726.73

ng/l

3.18

204

930

Other CVD (FINNGEN)

270

2.17

8.59

1.0

731.47

701.93

ng/l

0.23

184

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

131

2.92

8.51

1.1

1.0

705.27

679.84

ng/l

0.12

Diseases of oesophagus, stomach and duodenum

412

1784

1.38

8.46

1.0

780.07

743.26

ng/l

0.80

297

1213

Mental and behavioural disorders due to alcohol, excluding acute intoxication

189

1187

1.59

8.43

1.0

813.81

752.10

ng/l

1.06

134

828

External causes of morbidity and mortality

242

788

1.54

8.38

1.0

722.73

738.90

ng/l

0.21

165

536

Personality disorders

467

1.95

8.35

1.0

829.05

755.51

ng/l

0.84

333

Nerve, nerve root and plexus disorders

417

1859

1.38

8.35

1.0

785.93

734.54

ng/l

1.39

303

1256

Malignant neoplasm of respiratory system and intrathoracic organs

591

0.29

8.15

1.0

629.94

699.97

ng/l

0.41

377

Persons encountering health services in other circumstances, wide

453

1719

1.36

8.12

1.0

808.91

722.87

ng/l

3.53

342

1139

Sleep apnoea

376

1767

1.38

7.77

1.0

799.36

728.38

ng/l

2.13

266

1207

Stroke, including SAH

279

1400

1.45

7.74

1.0

745.24

719.84

ng/l

0.34

177

944

Transient global amnesia

122

2.89

7.74

1.0

844.62

871.72

ng/l

0.13

Traumatic subarachnoid haemorrhage

7.46

7.68

1.1

1.0

732.89

759.67

ng/l

—

Heart failure and coronary heart disease

1015

0.51

7.58

1.0

777.09

700.81

ng/l

0.72

672

Rotator cuff syndrome

271

1345

1.45

7.52

1.0

831.38

727.21

ng/l

2.75

183

920

Migraine without aura

231

2.30

7.45

1.0

922.69

737.98

ng/l

1.50

162

Hyperplasia of prostate

175

621

1.60

7.43

1.0

698.58

757.60

ng/l

0.92

124

412

Alcohol use disorder, ICD-based

172

1097

1.57

7.41

1.0

813.89

744.94

ng/l

1.15

122

761

Diseases of oral cavity, salivary glands and jaws

247

855

1.49

7.39

1.0

706.75

713.58

ng/l

0.08

159

573

Dental operations

259

906

1.47

7.31

1.0

732.46

722.12

ng/l

0.12

166

602

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

3.89

7.29

1.0

861.14

856.57

ng/l

0.01

Hypertension, essential

306

1223

1.42

7.29

1.0

749.17

755.31

ng/l

0.09

223

852

Sleep apnoea, including avohilmo

389

1780

1.36

7.19

1.0

815.40

726.41

ng/l

3.06

273

1218

Mixed and other personality disorders

122

2.80

7.15

1.0

899.19

849.75

ng/l

0.20

GASTRO-related operations

271

938

1.45

7.12

1.0

772.05

733.79

ng/l

0.62

173

714

Any gastric operation

271

938

1.45

7.12

1.0

772.05

733.79

ng/l

0.62

173

714

Inflammatory diseases of the central nervous system

175

2.47

7.07

1.1

1.0

696.79

736.59

ng/l

0.21

112

Vascular dementia (undefined)

6.52

7.05

1.0

726.08

767.62

ng/l

0.14

Other CVD

489

1.85

7.04

1.0

720.10

698.84

ng/l

0.19

307

Spondylosis

227

1261

1.47

6.99

1.0

795.47

718.65

ng/l

1.55

135

899

Degeneration of nervous system due to alcohol

3.76

6.95

1.0

712.40

564.84

ng/l

0.89

Stroke, excluding SAH

261

1341

1.42

6.68

1.0

751.19

715.96

ng/l

0.50

166

897

Periodontitis

383

1915

1.34

6.67

1.0

754.95

744.56

ng/l

0.16

266

1312

Progressive supranuclear ophthalmoplegia (Steele-Richardson-Olszewski)

9.20

6.67

1.0

625.50

429.57

ng/l

—

Influenza and pneumonia

383

1820

1.34

6.63

1.0

752.11

752.87

ng/l

0.01

262

1265

Colorectal cancer

748

0.39

6.63

1.0

661.75

705.71

ng/l

0.32

476

Malignant neoplasm of bronchus and lung, including Hilmo

615

0.38

6.57

1.0

686.19

700.68

ng/l

0.07

393

Fracture of skull and facial bones

450

1.85

6.56

1.0

826.52

731.37

ng/l

0.84

312

Cervical disc disorders

152

973

1.57

6.51

1.0

802.86

720.60

ng/l

1.25

106

701

Cardiodefibrillation

1149

0.51

6.41

1.0

735.66

714.94

ng/l

0.11

756

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

267

2.11

6.40

1.0

772.58

817.40

ng/l

0.25

183

Chronic periodontitis, including avohilmo

380

1918

1.33

6.34

1.0

753.67

744.84

ng/l

0.13

263

1315

Retention of urine

154

812

1.56

6.32

1.0

675.92

721.15

ng/l

0.66

108

523

Other bacterial diseases

379

1810

1.33

6.29

1.0

752.93

749.37

ng/l

0.05

258

1252

Hypertensive diseases

300

1226

1.38

6.26

1.0

734.87

755.62

ng/l

0.36

218

853

Hypertension

300

1226

1.38

6.25

1.0

734.87

755.62

ng/l

0.36

218

853

Other bacterial diseases

367

1854

1.33

6.22

1.0

733.66

750.29

ng/l

0.29

256

1275

Acute and transient psychotic disorders

218

2.21

6.21

1.0

841.58

777.78

ng/l

0.35

145

Injuries to the thorax

177

1184

1.50

6.20

1.0

798.44

727.57

ng/l

1.26

112

800

Insomnia

302

1610

1.37

6.18

1.0

785.44

746.62

ng/l

0.78

212

1114

Type 2 diabetes, wide definition

338

1608

1.35

6.13

1.0

733.31

740.95

ng/l

0.12

229

1113

Diabetes medication

383

1716

1.32

6.13

1.0

759.32

741.09

ng/l

0.34

263

1185

Other and unspecified injuries of head

127

2.62

6.13

1.0

677.87

670.84

ng/l

0.04

All kidney diseases

364

1874

1.33

6.10

1.0

730.26

752.10

ng/l

0.42

262

1277

Colorectal adenocarcinoma

629

0.36

6.03

1.0

658.50

705.69

ng/l

0.31

401

Specific personality disorders

384

1.88

6.02

1.0

815.40

757.60

ng/l

0.54

273

Diseases of the ear and mastoid process

416

1594

1.31

6.01

1.0

779.48

740.65

ng/l

0.89

281

1111

Implicit fungal Sepsis

3.37

6.01

1.0

1008.87

539.73

ng/l

2.30

Restless leg syndrome

316

1.97

5.95

1.0

815.72

722.17

ng/l

0.77

205

All pneumoniae

367

1857

1.32

5.93

1.0

740.38

753.23

ng/l

0.20

252

1287

All influenza

100

593

1.69

5.87

1.0

756.53

739.32

ng/l

0.13

401

Status epilepticus

3.31

5.87

1.0

911.73

641.24

ng/l

1.48

Alcohol dependence

113

693

1.64

5.84

1.0

797.47

734.93

ng/l

0.74

473

Endocrine, nutritional and metabolic diseases

263

952

1.40

5.82

1.0

755.14

722.10

ng/l

0.56

186

675

Caries of dentine, including avohilmo

307

1153

1.36

5.76

1.0

760.50

705.30

ng/l

1.23

210

767

Phobic anxiety disorders

125

2.56

5.75

1.0

959.26

769.97

ng/l

1.15

Disturbances of smell and taste

4.90

5.74

1.1

1.0

748.70

483.00

ng/l

—

252

2.07

5.74

1.0

799.91

738.56

ng/l

0.55

164

Other lack of coordination

5.66

5.71

1.2

1.0

1120.33

567.93

ng/l

—

Sequelae of injuries, of poisoning and of other consequences of external causes

553

1.71

5.70

1.0

751.06

744.08

ng/l

0.05

379

Other and unspecified polyneuropathies, also in other diseases

540

1.71

5.64

1.0

796.56

710.82

ng/l

0.97

351

Symptoms and signs concerning food and fluid intake

202

2.19

5.56

1.0

667.17

690.31

ng/l

0.10

128

Injuries to the shoulder and upper arm

320

1943

1.33

5.53

1.0

771.32

741.81

ng/l

0.51

220

1329

Dystonia

105

2.69

5.50

1.1

1.0

873.17

696.55

ng/l

0.99

Later onset COPD

694

0.48

5.48

1.1

1.0

727.68

677.83

ng/l

0.38

420

COPD, hospital admissions

1250

0.60

5.48

1.1

1.0

793.02

706.95

ng/l

1.24

818

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

359

1873

1.31

5.45

1.0

722.89

755.37

ng/l

0.67

247

1298

Dental caries, including avohilmo

292

1103

1.36

5.37

1.0

746.83

702.07

ng/l

0.87

198

732

Pneumonias (Asthma/COPD co-morbidities)

362

1865

1.30

5.36

1.0

732.40

754.32

ng/l

0.39

248

1293

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

366

1.84

5.36

1.0

689.84

762.24

ng/l

0.69

256

Other problems related to primary support group, including family circumstances

115

2.55

5.31

1.0

772.92

780.74

ng/l

0.03

Diseases of male genital organs

192

666

1.46

5.30

1.0

708.13

774.38

ng/l

1.10

138

444

Diplopia

309

1.92

5.28

1.0

722.48

733.32

ng/l

0.05

205

Heart failure, strict

134

1423

0.66

5.25

1.0

740.22

713.73

ng/l

0.29

100

916

COPD, early/later onset

1261

0.61

5.21

1.1

1.0

785.14

705.16

ng/l

1.16

825

COPD related to multimorbidity

1062

0.58

5.21

1.1

1.0

803.40

700.06

ng/l

1.37

684

Volume depletion

202

2.14

5.18

1.1

1.0

643.54

693.82

ng/l

0.28

122

Genitourinary diseases

206

723

1.43

5.18

1.0

702.45

778.09

ng/l

1.58

141

491

Cervicocranial syndrome

222

2.08

5.17

1.0

789.55

714.66

ng/l

0.42

161

All-cause Heart Failure

133

1411

0.66

5.17

1.0

739.99

713.11

ng/l

0.29

909

Pneumonia, organism unspecified

334

1789

1.31

5.16

1.0

713.88

752.20

ng/l

0.81

226

1238

Cystitis

296

1319

1.34

5.10

1.0

759.07

725.67

ng/l

0.58

205

887

Soft tissue disorders

346

1362

1.31

5.06

1.0

773.84

726.73

ng/l

1.07

233

930

Vascular syndromes of brain in cerebrovascular disorders

3.30

5.03

1.1

1.0

840.90

822.24

ng/l

—

Continuous positive airway pressure

372

1.75

5.02

1.0

788.70

671.59

ng/l

1.61

258

Hypertensive diseases (excluding secondary)

174

694

1.46

5.01

1.0

773.00

746.15

ng/l

0.35

126

511

Biguanides

370

1750

1.29

5.00

1.0

749.70

746.22

ng/l

0.05

253

1213

Fungal Sepsis

2.98

4.99

1.0

1008.87

543.92

ng/l

2.28

COPD, hospital admissions 3, with asthma pneumonia sepsis

695

0.49

4.99

1.1

1.0

744.50

705.82

ng/l

0.29

445

Ischaemic Stroke, excluding all haemorrhages

235

1278

1.37

4.98

1.0

757.32

707.74

ng/l

0.74

152

846

Explicit Sepsis

126

769

1.53

4.98

1.0

687.72

705.25

ng/l

0.17

455

Fracture at wrist and hand level

119

769

1.55

4.96

1.0

781.04

744.59

ng/l

0.36

522

COPD, hospital admissions 1, only main diagnosis

907

0.56

4.93

1.1

1.0

777.82

709.10

ng/l

0.78

586

Other diseases of hard tissues of teeth

229

855

1.39

4.90

1.0

723.61

713.58

ng/l

0.12

155

573

Transport accidents

148

864

1.48

4.84

1.0

748.41

756.43

ng/l

0.08

101

586

Fracture of rib(s), sternum and thoracic spine

123

809

1.52

4.80

1.0

782.31

730.21

ng/l

0.64

544

Hypersomnia

5.30

4.79

1.1

1.0

1036.00

637.33

ng/l

—

Diseases of the myoneural junction and muscle

299

1.88

4.77

1.0

603.91

718.82

ng/l

0.96

193

Lung cancer and mesothelioma

544

0.44

4.75

1.0

686.19

675.10

ng/l

0.05

353

Migraine

137

744

1.49

4.75

1.0

869.96

714.49

ng/l

2.91

520

Diseases of the musculoskeletal system and connective tissue

162

554

1.47

4.70

1.0

791.27

694.90

ng/l

1.59

106

391

Other (not insulin) diabetes medications

369

1713

1.28

4.69

1.0

747.76

741.65

ng/l

0.09

254

1184

Hypothyroidism, strict autoimmune, 3 medication purchases required

297

1531

1.31

4.65

1.0

790.42

727.73

ng/l

1.41

180

1067

Exposure to unspecified factor

349

1964

1.28

4.60

1.0

744.05

747.72

ng/l

0.05

265

1321

Hypothyroidism, drug reimbursement

109

2.27

4.59

1.0

884.22

711.93

ng/l

1.06

Emotionally unstable personality disorder

134

2.32

4.58

1.0

874.47

857.13

ng/l

0.07

Visual disturbances and blindness

189

1362

1.39

4.57

1.0

805.47

719.81

ng/l

1.38

126

917

Visual disturbances

175

1248

1.41

4.52

1.0

787.42

724.31

ng/l

0.88

117

843

Other chronic obstructive pulmonary disease

1190

0.64

4.52

1.1

1.0

785.14

698.99

ng/l

1.29

775

Non-small cell lung cancer, including Hilmo

462

0.39

4.46

1.0

576.00

707.63

ng/l

0.80

291

Abnormalities of breathing

296

1316

1.31

4.46

1.0

790.30

724.51

ng/l

1.54

206

893

COPD

1236

0.65

4.45

1.1

1.0

783.04

701.03

ng/l

1.31

805

Other and unspecified myopathies

202

2.04

4.42

1.0

507.13

679.60

ng/l

1.37

126

Hypoglycaemia, other or unspecified

124

2.35

4.41

1.1

1.0

772.95

672.69

ng/l

0.61

Disorders of eyelid, lacrimal system and orbit

316

1869

1.29

4.37

1.0

754.25

734.40

ng/l

0.30

206

1286

Malignant neoplasm of colon, including Hilmo

597

0.45

4.36

1.0

597.63

703.95

ng/l

1.06

379

Hard cardiovascular diseases

342

1597

1.28

4.36

1.0

763.99

744.04

ng/l

0.35

230

1128

Hypothyreosis and Thyroxine purchase for inclusion criteria

325

1662

1.28

4.36

1.0

781.99

728.35

ng/l

1.17

200

1154

Diarrhoea and gastroenteritis of presumed infectious origin

230

1551

1.34

4.34

1.0

778.79

744.50

ng/l

0.52

164

1037

Bacterial infection, other or unspecified

212

1361

1.35

4.31

1.0

708.06

726.25

ng/l

0.24

149

899

Disorders of ocular muscles, binocular movement, accommodation and refraction

148

1025

1.43

4.30

1.0

764.07

745.24

ng/l

0.17

709

Cervicobrachial syndrome

513

1.62

4.28

1.0

817.77

714.00

ng/l

0.82

376

Malignant neoplasm of colon

451

0.38

4.27

1.0

659.20

706.77

ng/l

—

282

Oter anti-inflammatory and antirheumatic agents, non-steroids

301

1.64

4.27

1.0

789.98

697.90

ng/l

1.10

204

Disorders of lens

296

1427

1.30

4.25

1.0

779.77

737.31

ng/l

0.83

207

1002

COPD, hospital admission 2, with asthma infections

825

0.57

4.25

1.1

1.0

740.05

708.49

ng/l

0.27

536

Other chronic obstructive pulmonary disease, including avohilmo

124

1493

0.68

4.25

1.0

764.39

717.31

ng/l

0.67

979

Fracture of neck

139

2.25

4.25

1.1

1.0

763.74

648.43

ng/l

0.61

Migraine with aura

355

1.75

4.24

1.0

773.38

721.44

ng/l

0.40

241

Migraine without aura and triptan purchases

185

2.06

4.23

1.0

926.11

743.62

ng/l

1.24

130

Persons encountering health services for other counselling and medical advice, not elsewhere classified

396

1719

1.25

4.22

1.0

821.73

722.87

ng/l

3.74

293

1139

Fall involving bed

2.93

4.18

1.1

1.0

729.20

574.03

ng/l

—

Heart failure,strict

129

1315

0.69

4.17

1.0

744.38

714.10

ng/l

0.33

867

Polyneuropathies and other disorders of the peripheral nervous system

611

1.56

4.17

1.0

796.56

716.86

ng/l

0.88

401

Schizophrenia

323

1.77

4.06

1.0

737.41

755.33

ng/l

0.12

227

Bacterial infection, other or unspecified

227

1448

1.33

4.06

1.0

704.99

727.01

ng/l

0.32

158

964

Other/unspecified dorsalgia

126

857

1.46

4.06

1.0

825.30

713.10

ng/l

1.71

611

Other disorders of fluid, electrolyte and acid-base balance

125

815

1.46

4.05

1.0

759.20

708.31

ng/l

0.62

520

Certain infectious and parasitic diseases

275

1055

1.31

4.05

1.0

755.06

723.42

ng/l

0.53

186

727

Symptoms and signs involving the digestive system and abdomen

357

1417

1.26

4.05

1.0

750.96

736.08

ng/l

0.23

245

965

Diseases of pulp and periapical tissues and dental caries

256

996

1.32

4.03

1.0

746.94

693.78

ng/l

1.05

171

654

Injuries to the abdomen, lower back, lumbar spine and pelvis

135

931

1.44

4.00

1.0

752.46

719.30

ng/l

0.33

616

Injury, poisoning and certain other consequences of external causes

174

624

1.40

3.98

1.0

726.60

731.94

ng/l

0.05

115

436

Somatoform disorder

305

1.78

3.91

1.0

853.68

725.20

ng/l

1.01

203

Cramp and spasm

2.52

3.88

1.1

1.0

903.20

650.74

ng/l

1.42

Pain in joint

200

946

1.35

3.86

1.0

833.59

713.65

ng/l

2.94

148

665

Gastro-oesophageal reflux disease

259

1731

1.29

3.86

1.0

798.99

740.58

ng/l

1.12

179

1178

Hypothyroidism, strict autoimmune

262

1330

1.30

3.86

1.0

780.03

711.15

ng/l

1.46

159

930

Injuries to the wrist and hand

348

1930

1.25

3.83

1.0

760.61

744.95

ng/l

0.26

261

1308

Disorders of choroid and retina

317

1787

1.26

3.81

1.0

733.81

736.95

ng/l

0.04

222

1207

Pain (limb, back, neck, head abdominally)

251

962

1.31

3.76

1.0

758.02

713.36

ng/l

0.78

165

669

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

102

1190

0.68

3.75

1.0

769.51

744.67

ng/l

0.20

828

Special screening examination for infectious and parasitic diseases

187

1.85

3.73

1.0

859.38

721.80

ng/l

1.36

152

Injuries to the elbow and forearm

239

1621

1.30

3.70

1.0

717.84

743.41

ng/l

0.37

163

1109

Used for control exclusion in common control thyroid runs

364

1479

1.24

3.67

1.0

814.87

720.78

ng/l

3.07

237

1041

Primary hyperparathyroidism

275

1.79

3.65

1.1

1.0

892.18

693.95

ng/l

2.17

177

Hypothyroidism, other/unspecified

307

1605

1.26

3.60

1.0

783.28

730.47

ng/l

1.09

190

1119

Pedestrian injured in transport accident

130

2.17

3.57

1.0

668.06

682.77

ng/l

0.05

Diabetes mellitus

354

1672

1.24

3.53

1.0

749.80

740.61

ng/l

0.15

241

1157

Pain, not elsewhere classified

540

1.54

3.51

1.0

777.40

736.14

ng/l

0.33

377

Diverticular disease of intestine

291

1472

1.26

3.51

1.0

791.33

730.06

ng/l

1.17

193

1016

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

344

1672

1.24

3.51

1.0

769.87

740.61

ng/l

0.58

238

1157

Senile cataract

279

1347

1.27

3.50

1.0

749.02

730.48

ng/l

0.28

192

942

Systemic atrophies primarily affecting the central nervous system

2.38

3.49

1.1

1.0

795.70

599.04

ng/l

—

Fibromyalgia

138

2.11

3.48

1.0

994.25

736.75

ng/l

2.31

Other diseases of pleura

1222

0.68

3.48

1.0

741.02

708.94

ng/l

0.27

799

Any event in cancer register

227

1719

0.78

3.42

1.0

752.84

754.76

ng/l

0.02

163

1181

Diabetes, varying definitions

352

1674

1.23

3.41

1.0

750.29

740.28

ng/l

0.16

240

1158

Dipeptidyl peptidase 4 (DPP-4) inhibitors

231

1439

1.29

3.36

1.0

725.55

723.82

ng/l

0.02

152

966

Other specified/unspecified disorders of bone/cartilage

2.86

3.36

1.0

910.60

679.00

ng/l

—

313

1522

1.25

3.34

1.0

734.98

737.25

ng/l

0.03

215

1049

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

313

1522

1.25

3.34

1.0

734.98

737.25

ng/l

0.03

215

1049

Fall on same level involving ice and snow

203

1560

1.30

3.34

1.0

726.19

735.99

ng/l

0.11

128

1067

Hypo-osmolality and hyponatraemia

457

1.57

3.34

1.0

797.31

712.83

ng/l

0.79

296

Fissure and fistula of anal and rectal regions

620

1.49

3.33

1.0

729.80

720.36

ng/l

0.06

426

Hernia

334

1816

1.23

3.32

1.0

757.89

747.76

ng/l

0.14

226

1255

Nontraumatic intracranial haemmorrhage

484

1.55

3.32

1.0

621.68

704.68

ng/l

0.80

316

Unspecified urinary incontinence

204

1.87

3.29

1.0

749.44

702.42

ng/l

0.23

128

Type 2 diabetes

351

1670

1.23

3.29

1.0

748.60

739.88

ng/l

0.14

238

1156

Later onset COPD, excluding more controls

545

0.57

3.27

1.1

1.0

743.97

671.38

ng/l

0.57

336

Meningitis

2.31

3.26

1.1

1.0

734.14

732.46

ng/l

0.01

Disorders of the thyroid gland

325

1717

1.23

3.22

1.0

791.68

730.36

ng/l

1.43

204

1203

Diabetes, insulin treatment (Kela reimbursement)

364

1804

1.22

3.21

1.0

764.67

744.18

ng/l

0.39

253

1240

Renal tubulo-interstitial diseases

306

1844

1.24

3.18

1.0

713.83

740.91

ng/l

0.51

217

1241

Postmenopausal osteoporosis with pathological fracture

137

2.06

3.16

1.0

764.86

723.02

ng/l

0.12

Eating disorders

2.31

3.15

1.0

990.14

764.58

ng/l

1.28

Malignant neoplasm of liver and intrahepatic bile ducts

0.00

3.13

0.0

1.0

—

621.00

—

Other disorders of nervous system

131

2.07

3.12

1.0

836.50

728.73

ng/l

0.58

Oxycodone

1145

0.69

3.10

1.0

745.28

696.64

ng/l

0.54

759

Cardiovascular diseases (excluding rheumatic etc)

163

698

1.34

3.10

1.0

798.70

747.63

ng/l

0.66

113

513

Diseases of the eye and adnexa

253

999

1.27

3.10

1.0

767.18

756.63

ng/l

0.13

181

732

Voice disturbances

655

1.45

3.10

1.0

802.40

712.41

ng/l

1.38

433

Anomalies of pupillary function

3.70

3.09

1.0

854.00

709.16

ng/l

—

Oedema, not elsewhere classified

104

721

1.43

3.06

1.0

806.75

717.29

ng/l

1.25

487

Other disorders of glucose regulation and pancreatic internal secretion

160

1.95

3.04

1.1

1.0

781.59

691.83

ng/l

0.58

102

Gingivitis and periodontal diseases

361

1533

1.22

3.03

1.0

741.92

744.89

ng/l

0.04

239

1051

Other general symptoms and signs

2.66

3.00

1.0

994.67

663.97

ng/l

—

Fracture of forearm

190

1346

1.29

2.99

1.0

689.26

738.98

ng/l

0.79

130

916

Peripheral arterial reconstruction

464

0.49

2.99

1.0

664.00

688.73

ng/l

0.13

290

Bacterial meningitis

2.52

2.87

1.1

1.0

716.45

650.54

ng/l

0.25

Acute alcohol intoxication

616

1.45

2.87

1.0

795.41

737.71

ng/l

0.64

419

Symptoms and signs involving the circulatory and respiratory systems

321

1316

1.22

2.86

1.0

752.46

724.51

ng/l

0.51

227

893

Acute tubulo-interstitial nephritis

219

1497

1.26

2.85

1.1

1.0

704.37

722.11

ng/l

0.24

156

990

Injury of muscle and tendon at shoulder and upper arm level

143

1074

1.33

2.84

1.0

763.78

728.43

ng/l

0.39

101

736

Disorders of other endocrine glands

136

997

1.34

2.83

1.0

845.90

712.42

ng/l

3.04

659

Certain infectious and parasitic diseases

335

1381

1.22

2.82

1.0

764.27

739.60

ng/l

0.42

233

942

Solid cancers, helper endpoint

226

1672

0.80

2.82

1.0

750.29

756.31

ng/l

0.07

158

1154

Psoriasis

746

0.62

2.80

1.0

830.90

729.74

ng/l

0.60

518

Other fall from one level to another

497

1.49

2.78

1.0

777.54

746.66

ng/l

0.21

331

Polyuria

596

1.45

2.77

1.0

769.51

723.34

ng/l

0.40

390

Disorders of parathyroid gland

508

1.48

2.76

1.0

846.20

695.49

ng/l

1.95

326

Insulin, intermediate and long-acting

195

1492

1.27

2.73

1.0

785.36

726.21

ng/l

1.01

136

1001

Injuries to the hip and thigh

166

1159

1.30

2.72

1.0

661.21

716.19

ng/l

0.84

105

763

Other intracranial haemorrhages

2.44

2.71

1.1

1.0

411.80

611.39

ng/l

—

Exclusions for E4_PCOS_BROAD

340

1.59

2.71

1.0

801.84

756.48

ng/l

0.35

226

Endovascular or surgical operations to intracerebral aneurysms

153

1.91

2.70

1.1

1.0

548.54

751.13

ng/l

1.63

Diseases of tongue

125

2.01

2.70

1.0

953.80

674.70

ng/l

1.89

Early lumbar disc prolapse, operated

2.15

2.70

1.0

943.87

797.54

ng/l

0.66

Basal cell carcinoma, including avohilmo

131

1200

0.75

2.68

1.1

1.0

704.24

713.90

ng/l

0.08

796

Other disorders of penis

204

1.77

2.68

1.1

1.0

714.33

776.94

ng/l

0.52

135

Gout, strict definition

549

0.56

2.68

1.0

742.12

700.79

ng/l

0.16

355

Complications of other internal prosthetic devices, implants and grafts

2.19

2.67

1.0

876.00

644.40

ng/l

—

Exclusions for E4_PCOS_CONSORTIUM

210

1040

1.27

2.67

1.0

794.47

738.51

ng/l

1.13

156

717

Inguinal hernia

208

1100

1.27

2.67

1.0

726.65

751.47

ng/l

0.31

136

745

Fracture of lumbar spine and pelvis

534

1.46

2.67

1.0

768.37

693.69

ng/l

0.67

342

Strabismus

542

1.46

2.66

1.0

769.47

743.93

ng/l

0.14

375

Carcinoma in situ of skin

215

0.37

2.66

1.1

1.0

588.63

653.23

ng/l

—

130

Migraine with aura and triptan purchases

190

1.79

2.65

1.0

800.54

731.77

ng/l

0.40

133

3.17

2.65

1.0

683.67

721.27

ng/l

—

Hyperparathyroidism

442

1.50

2.62

1.0

857.16

693.36

ng/l

2.15

280

Redundant prepuce, phimosis and paraphimosis

411

1.52

2.61

1.0

829.02

788.42

ng/l

0.25

275

Mental disorders, not otherwise specified

113

2.04

2.61

1.0

743.28

785.40

ng/l

0.16

Acute alcohol intoxication, ICD10

464

1.49

2.61

1.0

787.69

745.22

ng/l

0.38

319

Diabetic retinopathy, excluding more controls

333

1.45

2.59

1.0

824.19

764.87

ng/l

0.47

221

Cardiomyopathy

554

0.58

2.56

1.0

716.76

735.40

ng/l

0.09

360

Impingement syndrome of shoulder

100

724

1.38

2.55

1.0

769.18

725.44

ng/l

0.40

502

Disorders of vestibular function (Vertigo)

173

1334

1.28

2.54

1.0

729.35

729.29

ng/l

0.00

114

899

Unstable angina pectoris

978

0.72

2.53

1.0

699.47

708.62

ng/l

0.07

653

Viral and other specified intestinal infections

262

1.64

2.53

1.1

1.0

692.59

746.38

ng/l

0.33

167

Abdominal and pelvic pain

338

1417

1.20

2.52

1.0

764.14

736.08

ng/l

0.50

235

965

Colonic or urogenital fistula

684

1.39

2.51

1.0

726.38

738.32

ng/l

0.09

460

Abnormal findings in secretions and smears from cervix uteri vagina vulva

759

0.69

2.51

1.0

789.66

758.31

ng/l

0.22

547

Atherosclerosis, excluding cerebral and coronary sclerosis

1052

0.73

2.49

1.0

707.46

692.15

ng/l

0.14

675

Other disorders of eye and adnexa

286

1.61

2.47

1.0

806.26

748.82

ng/l

0.33

182

Cardiovascular diseases

139

564

1.33

2.47

1.0

838.93

744.00

ng/l

1.35

419

Amyloidosis, other/unspecified

2.70

2.46

1.1

1.0

634.92

620.23

ng/l

0.03

Irritable bowel syndrome

620

1.41

2.45

1.1

1.0

796.97

716.42

ng/l

0.97

417

Paracetamol or NSAID medication

132

1.68

2.45

1.0

599.73

720.20

ng/l

1.21

Disorders of synovium and tendon

178

1232

1.27

2.43

1.0

687.30

729.57

ng/l

0.85

133

853

Hepatocellular carcinoma

0.00

2.43

0.0

1.0

—

602.78

—

Type 2 diabetes, definitions combined

338

1667

1.19

2.42

1.0

745.58

740.47

ng/l

0.07

225

1154

Finngen Rheumatological endpoints

321

1527

1.20

2.41

1.0

771.06

731.41

ng/l

0.84

223

1056

Excessive earwax

197

1542

1.25

2.41

1.0

691.22

721.55

ng/l

0.43

121

1031

Superficial injury of abdomen, lower back and pelvis

304

1.58

2.40

1.0

772.07

724.06

ng/l

0.25

203

Fracture of femur

617

1.38

2.39

1.0

621.00

691.51

ng/l

0.80

389

Injuries to the neck

457

1.47

2.39

1.0

753.28

752.71

ng/l

0.00

319

Substance use, excluding alcohol

376

1.52

2.39

1.1

1.0

841.66

752.21

ng/l

0.95

265

Missing teeth due to accident, extraction or parodontitis

231

1778

1.23

2.38

1.0

752.23

730.82

ng/l

0.26

139

1228

Allergic rhinitis

518

1.43

2.36

1.0

787.44

755.71

ng/l

0.31

355

Other heart diseases

139

694

1.31

2.36

1.0

774.32

747.26

ng/l

0.26

511

Type 2 diabetes, strict (exclude DM1)

338

1672

1.19

2.35

1.0

746.17

741.29

ng/l

0.07

226

1158

Aortic aneurysm

685

0.64

2.32

1.0

777.37

704.43

ng/l

0.63

437

Intracerebral haemorrhage

299

1.58

2.32

1.0

608.30

679.28

ng/l

0.50

186

Neuromuscular dysfunction of bladder

199

1.71

2.31

1.1

1.0

590.30

710.23

ng/l

1.06

129

Subjective visual disturbances

602

1.40

2.31

1.0

766.51

719.53

ng/l

0.38

413

Early lumbar disc prolapse operation

119

1.94

2.30

1.0

870.59

886.62

ng/l

0.05

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

330

1814

1.18

2.29

1.0

747.27

749.05

ng/l

0.02

241

1241

Calcific aortic valvular stenosis, operated

814

0.68

2.29

1.0

673.21

702.83

ng/l

0.23

505

Calcific aortic valvular stenosis

814

0.68

2.29

1.0

673.21

702.83

ng/l

0.23

505

Operations 2 for CAVS

813

0.68

2.27

1.0

673.21

702.83

ng/l

0.23

504

Calcific aortic valvular stenosis, diagnosis (helper)

813

0.68

2.27

1.0

673.21

702.83

ng/l

0.23

504

Basal cell carcinoma

129

1158

0.77

2.27

1.1

1.0

707.72

710.92

ng/l

0.03

761

Assault by bodily force

2.07

2.27

1.1

1.0

692.31

826.50

ng/l

0.82

Anorexia (incl.atypical)

2.56

2.26

1.1

1.0

1149.60

645.88

ng/l

—

Pain in thoracic spine

301

1.57

2.26

1.0

891.74

715.60

ng/l

1.48

220

Disorders of brain, other and unspecified

3.94

2.26

1.0

790.43

540.00

ng/l

—

Alcohol abuse, main dg

349

1.52

2.26

1.0

799.36

750.44

ng/l

0.37

244

Malignant neoplasm of small intestine

0.00

2.25

0.0

1.0

—

641.56

—

Weight loss

239

1.64

2.25

1.1

1.0

688.96

685.81

ng/l

0.01

151

Gastrointestinal diseases

184

732

1.26

2.24

1.0

772.28

715.28

ng/l

0.83

123

501

Malignant neoplasm

233

1674

0.82

2.24

1.0

754.57

756.70

ng/l

0.02

168

1155

Mixed conductive and sensorineural hearing loss

318

1.55

2.23

1.0

707.24

702.87

ng/l

0.03

214

Malignant neoplasm of prostate, including Hilmo

702

0.73

2.22

1.0

671.70

734.52

ng/l

0.81

473

Type of accident

666

1.37

2.22

1.0

756.56

723.86

ng/l

0.28

447

Nausea and vomiting

586

1.39

2.22

1.0

767.73

708.86

ng/l

0.50

368

COPD (mode)

814

0.71

2.21

1.1

1.0

794.76

695.28

ng/l

1.37

526

Other specific joint derangements/joint disorders

227

1200

1.22

2.21

1.0

820.09

724.01

ng/l

2.30

162

835

Other disorders of lacrimal gland

121

925

1.31

2.21

1.0

742.71

721.59

ng/l

0.19

626

Calcific aortic valvular stenosis, including rheumatic fever

818

0.69

2.20

1.0

686.49

702.92

ng/l

0.12

505

Benign neoplasm: Cerebral meninges

233

1.64

2.19

1.0

869.48

698.76

ng/l

0.99

144

Non-ischemic cardiomyopathy

813

0.71

2.19

1.0

664.35

705.35

ng/l

0.37

525

Chronic apical periodontitis

370

1801

1.17

2.19

1.0

775.94

732.58

ng/l

1.02

252

1225

Gout, unspecified

615

0.63

2.19

1.0

732.72

714.90

ng/l

0.07

398

Presbyopia

143

1.83

2.19

1.0

862.21

769.31

ng/l

0.38

Cardiomyopathy (excluding other)

402

0.55

2.18

1.0

748.31

726.86

ng/l

0.09

262

Other ill-defined and unspecified causes of mortality

180

1.73

2.18

1.0

563.13

647.63

ng/l

0.61

108

Rheumatism, unspecified

329

1.52

2.15

1.0

947.76

684.89

ng/l

2.87

223

Diseases of inner ear

198

1559

1.23

2.15

1.0

717.31

729.96

ng/l

0.15

131

1058

Pleural effusion

438

0.57

2.15

1.0

610.87

690.74

ng/l

0.50

279

Valvular operations

463

0.58

2.14

1.0

757.17

715.28

ng/l

0.18

297

Retinal detachments and breaks

134

1044

1.29

2.14

1.0

736.72

719.92

ng/l

0.16

100

683

Other gastritis (incl. Duodenitis)

603

1.38

2.14

1.0

691.93

721.80

ng/l

0.23

397

Tonsillectomy and adenotomy

677

0.71

2.13

1.0

842.00

779.10

ng/l

0.45

489

Primary gonarthrosis, bilateral

140

1521

0.79

2.12

1.0

756.66

720.97

ng/l

0.40

1024

In situ neoplasms

1013

0.72

2.12

1.0

700.08

702.36

ng/l

0.02

658

Other cataract

175

1063

1.25

2.11

1.0

744.50

726.55

ng/l

0.19

125

728

Abnormal findings on diagnostic imaging of other body structures

371

0.54

2.10

1.0

587.38

701.55

ng/l

0.83

244

Benign neoplasm of brain and other parts of central nervous system

138

1.82

2.09

1.1

1.0

563.13

684.71

ng/l

1.11

Cough

141

1049

1.27

2.08

1.0

735.34

712.64

ng/l

0.28

108

705

Supplementary factors related to causes of morbidity and mortality classified elsewhere

717

1.34

2.08

1.0

777.56

722.60

ng/l

0.56

483

Intestinal infectious diseases

388

1911

1.16

2.08

1.0

769.05

741.59

ng/l

0.54

279

1296

Non-rheumatic valve diseases

131

1207

0.78

2.07

1.0

758.65

730.73

ng/l

0.25

813

Bronchitis, not specified as acute or chronic

191

1.68

2.06

1.1

1.0

664.43

725.93

ng/l

0.47

117

Abnormal blood-pressure reading, without diagnosis

103

1.95

2.05

1.1

1.0

731.08

680.59

ng/l

0.12

Fall on and from stairs and steps

634

1.36

2.04

1.0

807.71

733.86

ng/l

0.81

430

Asthma (mode)

263

1178

1.20

2.02

1.0

798.19

729.66

ng/l

1.42

179

796

Abnormal findings on diagnostic imaging of lung

121

1483

0.78

2.00

1.0

765.00

717.08

ng/l

0.56

967

Cardiomyopathies, Primary/intrinsic

390

0.56

1.99

1.0

748.31

729.72

ng/l

0.07

255

Malignant neoplasm of prostate

679

0.74

1.99

1.0

681.22

728.28

ng/l

0.56

459

Ocular pain

148

1.76

1.98

1.1

1.0

795.60

710.20

ng/l

0.40

Benign paroxysmal vertigo

102

776

1.32

1.97

1.1

1.0

714.13

707.13

ng/l

0.06

516

Autoimmune diseases

363

1589

1.16

1.97

1.0

793.44

723.66

ng/l

1.97

236

1116

Tramadol

277

1438

1.18

1.95

1.0

805.88

719.67

ng/l

2.48

197

977

Osteoporosis

653

1.33

1.95

1.0

683.35

679.59

ng/l

0.02

420

Asthma and allergy, excluding more controls

184

1.67

1.95

1.1

1.0

886.00

719.28

ng/l

1.31

124

Other respiratory diseases principally affecting the interstitium

499

0.62

1.94

1.0

844.42

689.45

ng/l

1.15

321

Malignant neoplasm of skin

153

1304

0.80

1.94

1.1

1.0

676.08

727.13

ng/l

0.72

100

875

Peripheral artery disease

108

1112

0.77

1.94

1.0

744.51

697.38

ng/l

0.52

719

Psoriatic arthropathies

242

0.45

1.93

1.0

1006.50

707.09

ng/l

—

171

Type 2 diabetes, definitions combined, including avohilmo

330

1648

1.17

1.93

1.0

734.30

740.38

ng/l

0.09

223

1140

Abnormal weight loss

226

1.60

1.93

1.1

1.0

695.84

686.99

ng/l

0.03

141

Benign neoplasm of meninges

258

1.56

1.92

1.0

849.38

688.64

ng/l

0.94

163

Actinic keratosis

1069

0.75

1.92

1.0

723.81

675.23

ng/l

0.50

669

Viral and other specified intestinal infections

366

1.45

1.91

1.1

1.0

712.40

758.85

ng/l

0.32

237

Persons encountering health services in other circumstances

121

942

1.28

1.90

1.0

806.83

710.51

ng/l

1.58

614

Bacterial, viral and other infectious agents

150

1.74

1.90

1.0

753.29

797.64

ng/l

0.21

101

Valvular heart disease excluding rheumatic fever

133

1209

0.79

1.90

1.0

755.21

730.43

ng/l

0.22

814

Use of disulfiram, acamprosate or naltrexone

196

1.64

1.89

1.0

825.50

806.42

ng/l

0.08

134

Secondary malignant neoplasm of other and unspecified sites

0.00

1.89

0.0

1.0

—

625.19

—

Pedestrian injured in collision with pedal cycle

2.32

1.88

1.0

676.71

567.79

ng/l

—

Colectomy operation

457

0.61

1.87

1.0

806.33

721.75

ng/l

0.43

300

Any reimbursement code in KELA

157

629

1.25

1.87

1.0

833.16

743.24

ng/l

1.40

110

447

Insulin medication

202

1408

1.21

1.86

1.0

779.52

728.85

ng/l

0.81

140

951

Gonarthrosis, primary, with knee surgery

167

1627

0.82

1.86

1.0

789.72

718.07

ng/l

1.05

1102

751

0.72

1.86

1.1

1.0

668.05

673.42

ng/l

0.03

463

Autoimmune diseases excluding thyroid diseases, strict definition

329

1550

1.16

1.85

1.0

832.83

722.84

ng/l

3.72

229

1089

Pneumonitis due to solids and liquids

190

1.64

1.84

1.0

721.15

639.56

ng/l

0.49

117

Paralytic strabismus

167

1.68

1.84

1.0

735.93

670.03

ng/l

0.24

100

Periapical abscess

152

1229

1.24

1.83

1.0

758.91

746.55

ng/l

0.14

111

852

Asthma

265

1175

1.18

1.82

1.0

812.86

729.37

ng/l

1.90

184

794

Vasomotor and allergic rhinitis

103

780

1.30

1.82

1.0

779.80

726.70

ng/l

0.69

544

Hypertrophic disorders of skin

2.06

1.80

1.0

843.63

747.48

ng/l

—

Cardiac arrhythmias

176

935

1.22

1.80

1.0

805.70

748.34

ng/l

0.85

126

676

malignant neoplasm of male genital organs

693

0.75

1.80

1.0

697.95

731.62

ng/l

0.36

466

Other disorders of the musculoskeletal system and connective tissue

377

1.44

1.79

1.1

1.0

797.70

727.01

ng/l

0.44

252

Fibroblastic disorders

606

1.34

1.79

1.0

729.48

693.39

ng/l

0.34

415

Superficial injury of lower leg

529

1.36

1.78

1.0

750.77

730.78

ng/l

0.18

364

Malignant melanoma, including Hilmo

536

0.65

1.78

1.0

571.90

713.83

ng/l

1.24

348

Asthma and allergy

189

1.62

1.78

1.1

1.0

886.00

721.77

ng/l

1.29

128

Coronary artery bypass grafting

647

0.72

1.78

1.0

720.56

691.53

ng/l

0.16

421

Malignant melanoma

450

0.62

1.77

1.0

493.00

709.57

ng/l

3.98

286

Psoriasis vulgaris

474

0.63

1.76

1.0

918.47

735.21

ng/l

0.85

331

Pain associated with micturition

272

1.51

1.76

1.0

779.81

708.22

ng/l

0.46

175

Other postsurgical states

154

1.69

1.76

1.0

585.89

688.26

ng/l

—

Budesonide

313

1.47

1.75

1.0

843.11

746.95

ng/l

0.84

215

Malignant neoplasm, wide definition for exclusion

243

1678

0.85

1.74

1.0

754.81

757.13

ng/l

0.03

175

1159

Carbimazole or st.post thyroidectomy, condition for graves disease

472

0.63

1.73

1.0

771.32

730.91

ng/l

0.17

323

Flat foot [pes planus] (acquired)

231

0.47

1.73

1.0

707.83

650.06

ng/l

—

160

Crowding of teeth, including avohilmo

0.00

1.72

0.0

1.0

—

700.71

—

Benign neoplasm of colon, rectum, anus and anal canal

244

1802

1.18

1.72

1.0

738.97

732.46

ng/l

0.07

172

1210

Disorder of external ear, unspecified

2.14

1.72

1.1

1.0

683.63

621.75

ng/l

—

Use of pramipexole

576

1.34

1.71

1.0

789.84

696.52

ng/l

0.92

385

Maternal care related to the fetus and amniotic cavity and possible delivery problems

508

0.73

1.71

1.0

860.57

762.49

ng/l

0.96

383

Gout, idiopatic and unspecified

743

0.71

1.71

1.0

734.70

709.34

ng/l

0.13

491

Complications of surgical and medical care, not elsewhere classified

331

1970

1.15

1.71

1.0

777.39

740.61

ng/l

0.73

217

1362

Other malignant neoplasms of skin (=non-melanoma skin cancer)

141

1192

0.81

1.70

1.1

1.0

710.24

716.87

ng/l

0.06

789

Malignant neoplasm of breast, HER2-negative

817

0.78

1.69

1.0

744.28

739.95

ng/l

0.03

567

Pneumocystosis

0.00

1.69

0.0

1.0

—

602.78

—

malignant neoplasm of female genital organs

417

0.62

1.69

1.1

1.0

733.69

682.54

ng/l

0.22

263

Autoimmune diseases excluding thyroid diseases

335

1588

1.15

1.68

1.0

836.95

723.66

ng/l

4.01

233

1116

Drug-induced neutropenia

180

0.44

1.68

1.0

751.25

692.21

ng/l

—

112

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

153

1266

0.82

1.66

1.1

1.0

713.72

721.22

ng/l

0.07

847

Persons encountering health services for specific procedures, not carried out

149

1.68

1.66

1.0

854.76

702.37

ng/l

0.91

L02BG Aromatase inhibitors

876

0.74

1.66

1.0

718.16

730.26

ng/l

0.08

590

Asthma, excluding more controls

255

1132

1.18

1.66

1.0

822.47

730.83

ng/l

2.13

178

766

Bacterial, viral and other infectious agents

157

1.66

1.65

1.0

753.29

795.42

ng/l

0.20

105

Type 1 diabetes

520

1.35

1.63

1.0

925.65

760.73

ng/l

1.65

353

Renal failure

109

1210

0.80

1.61

1.0

783.07

700.41

ng/l

1.12

782

1152

0.79

1.61

1.0

719.61

683.37

ng/l

0.37

729

Ill-defined and unknown causes of mortality

214

1.55

1.59

1.0

569.94

663.37

ng/l

0.82

128

Malignant neoplasm of breast, HER-positive

778

0.76

1.59

1.0

722.13

736.05

ng/l

0.10

536

Hypertensive Heart Disease

602

0.73

1.58

1.0

745.84

713.84

ng/l

0.19

386

Malignant melanoma of skin, including Hilmo

447

0.65

1.56

1.0

580.06

712.18

ng/l

0.84

284

Viral pneumonia

297

1.45

1.55

1.0

771.03

730.71

ng/l

0.22

203

Heart failure and antihypertensive medication

517

0.73

1.55

1.0

817.68

735.84

ng/l

0.74

377

Hypertrophic scar

2.04

1.54

1.0

885.86

744.88

ng/l

—

Postpartum haemorrhage

262

0.58

1.54

1.0

794.58

809.24

ng/l

0.04

198

Diabetic neuropathy

239

1.50

1.53

1.1

1.0

802.44

726.72

ng/l

0.46

161

Malignant neoplasm of bladder, including Hilmo

357

0.61

1.53

1.0

655.25

688.01

ng/l

0.16

220

Oligomenorrhoea

0.00

1.52

0.0

1.0

—

682.26

—

Atrial fibrillation and flutter with reimbursement

567

0.75

1.52

1.0

730.59

719.59

ng/l

0.09

413

Coxarthrosis, primary, with hip surgery

125

1435

0.81

1.51

1.0

742.64

708.28

ng/l

0.43

944

Lesion of sciatic nerve

1.84

1.51

1.0

721.63

589.65

ng/l

—

Superficial injury of forearm

169

1.60

1.51

1.0

986.88

721.61

ng/l

1.04

112

Alcohol withdrawal state with delirium

185

1.57

1.51

1.0

770.39

711.28

ng/l

0.30

123

Vocal cord dysfunction

245

1.47

1.51

1.0

857.33

687.89

ng/l

1.33

172

Malignant neoplasm of heart, mediastinum and pleura, including Hilmo

0.00

1.50

0.0

1.0

—

636.25

—

Myocardial infarction, strict

131

1140

0.82

1.50

1.0

747.80

715.65

ng/l

0.33

765

Papulosquamous disorders

1120

0.78

1.49

1.0

832.73

734.26

ng/l

1.07

771

Other enthesopathies

784

1.26

1.49

1.0

869.14

733.92

ng/l

1.67

544

Malignant neoplasm of breast, ER-positive, including Hilmo

779

0.77

1.49

1.0

723.54

736.10

ng/l

0.09

537

1.86

1.49

1.0

723.00

570.67

ng/l

—

Abnormal spermatozoa

393

0.63

1.48

1.0

762.60

711.78

ng/l

0.18

259

Other and unspecified follicular disorders

2.01

1.48

1.0

752.14

583.44

ng/l

—

Faecal incontinence

210

1.53

1.48

1.0

666.42

656.57

ng/l

0.04

134

Superficial injury of hip and thigh

325

1.42

1.48

1.0

633.29

722.08

ng/l

0.72

209

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

565

1.31

1.47

1.0

723.02

753.94

ng/l

0.26

390

Hypogonadotropic hypogonadism

2.23

1.46

1.0

965.50

930.33

ng/l

—

Other menopausal disorders

416

0.73

1.46

1.0

721.57

726.40

ng/l

0.03

283

Leisure time condition

385

1.38

1.46

1.0

682.56

726.09

ng/l

0.38

256

Insulin, combination of fast acting with intermediate-acting or long-acting

202

1572

1.17

1.46

1.0

779.52

727.23

ng/l

0.86

140

1048

Osteopathies and chondropathies

188

1483

1.18

1.46

1.0

763.03

733.27

ng/l

0.39

122

1008

First line medication for Crohn's disease

287

1776

0.87

1.46

1.0

810.39

731.66

ng/l

2.17

198

1222

Panic disorder

163

1.60

1.45

1.0

951.82

766.57

ng/l

0.93

111

Osteoporosis with pathological fracture (FG)

179

1.57

1.45

1.0

764.86

674.81

ng/l

0.31

115

Lesion of lateral popliteal nerve

117

1.72

1.45

1.1

1.0

791.93

673.23

ng/l

0.39

Myocardial infarction, with ST-elevation

474

0.67

1.44

1.0

711.80

698.12

ng/l

0.06

305

Early onset COPD

684

0.73

1.44

1.0

832.03

726.36

ng/l

1.06

461

Caries of dentine

493

1.32

1.43

1.0

702.00

717.23

ng/l

0.11

345

Propionic acid derivatives

303

1.31

1.43

1.0

670.81

702.24

ng/l

0.21

205

Candidiasis

647

1.28

1.43

1.0

822.53

717.83

ng/l

1.19

437

Medicines for HER+ breast cancer

970

0.78

1.43

1.1

1.0

725.53

730.87

ng/l

0.04

661

Hyperlipidaemia, other/unspecified

145

1107

1.21

1.42

1.0

745.96

717.00

ng/l

0.28

103

713

Glaucoma

206

1515

1.17

1.42

1.0

728.60

718.21

ng/l

0.11

129

1006

Dialysis, with operation codes

352

0.62

1.42

1.0

666.62

708.64

ng/l

0.20

247

Disorders of skin appendages

132

1085

1.22

1.42

1.0

812.83

743.28

ng/l

0.81

754

Tongue abnormality

141

1.64

1.41

1.0

959.92

672.92

ng/l

1.70

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

841

0.77

1.41

1.1

1.0

696.73

757.11

ng/l

0.58

605

Struck by thrown, projected or falling objec

1.82

1.41

1.0

562.73

683.41

ng/l

0.83

Ménière disease

229

1.49

1.41

1.0

719.79

712.49

ng/l

0.03

142

Polycystic ovarian syndrome, consortium definition

186

931

1.18

1.40

1.0

820.56

723.16

ng/l

1.87

128

651

Inflammatory diseases of prostate (prostatitis)

312

1.41

1.40

1.1

1.0

772.71

771.74

ng/l

0.00

205

Heart failure and bmi 25plus

654

0.77

1.40

1.0

780.69

761.02

ng/l

0.13

425

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

423

0.66

1.40

1.0

698.14

726.89

ng/l

0.12

289

Tooth eruption problems

1.82

1.39

1.0

1003.80

768.19

ng/l

—

Psoriatic and enteropathic arthropathies

276

0.58

1.39

1.0

994.50

748.04

ng/l

—

194

Aneurysms, operations, SAH

406

1.36

1.39

1.0

601.96

721.00

ng/l

0.97

270

Congenital malformations of genital organs

1.81

1.38

1.0

987.18

765.28

ng/l

0.93

Reimbursement for rheumatic diseases

134

1607

0.83

1.38

1.0

840.21

732.51

ng/l

1.51

1104

Malignant neoplasm of breast

101

819

0.80

1.37

1.0

740.28

741.74

ng/l

0.01

569

Other diseases of the respiratory system

539

0.70

1.37

1.1

1.0

818.28

714.55

ng/l

0.49

350

Other respiratory disorders and diseases

539

0.70

1.37

1.1

1.0

818.28

714.55

ng/l

0.49

350

Retinal detachment with retinal break

356

1.38

1.37

1.1

1.0

783.17

727.29

ng/l

0.34

232

Assault

190

1.53

1.37

1.0

783.23

802.23

ng/l

0.09

132

Dysplasia of cervi uteri

323

0.67

1.36

1.0

699.91

741.20

ng/l

0.19

224

Radiculopathy

382

1.36

1.1

1.0

771.85

688.37

ng/l

0.49

267

Skin changes due to chronic exposure to nonionizing radiation

1090

0.80

1.35

1.0

717.07

675.84

ng/l

0.43

685

Melanocytic naevi

676

0.74

1.35

1.0

732.80

723.36

ng/l

0.05

461

Drug-induced osteoporosis with pathological fracture

0.00

1.35

0.0

1.0

—

627.91

—

Other interstitial pulmonary diseases

419

0.67

1.35

1.0

857.25

690.33

ng/l

1.22

268

Other/unspecified enthesopathies, not elsewhere classified

199

1.51

1.34

1.0

810.71

685.80

ng/l

0.71

133

Other noninfective gastroenteritis and colitis

530

1.30

1.34

1.0

811.92

719.21

ng/l

0.75

354

Ulcer of vagina/vulva

2.15

1.34

1.0

771.78

712.70

ng/l

—

Other strabismus

416

1.34

1.0

756.88

758.91

ng/l

0.01

286

Allergic asthma (mode)

434

1.33

1.0

801.08

698.42

ng/l

0.98

292

Medial epicondylitis

1.92

1.33

1.0

921.75

750.19

ng/l

—

Laparoscopic left hemicolectomy

0.00

1.33

0.0

1.0

—

587.13

—

Excessive vomiting in pregnancy

105

1.72

1.33

1.0

845.23

798.83

ng/l

0.14

Disorders of sclera, cornea, iris and ciliary body

169

1434

1.18

1.32

1.0

805.79

731.05

ng/l

1.21

123

974

Benign neoplasm of other and unspecified endocrine glands

333

1.38

1.32

1.0

818.12

729.29

ng/l

0.56

221

Enthesopathies of lower limb, excluding foot

514

1.31

1.32

1.0

873.65

716.24

ng/l

2.02

376

Interstitial lung disease

417

0.67

1.32

1.0

857.25

689.34

ng/l

1.23

267

Interstitial lung disease endpoints

417

0.67

1.32

1.0

857.25

689.34

ng/l

1.23

267

Allergic asthma (mode), excluding more controls

435

1.33

1.31

1.0

801.08

702.74

ng/l

0.92

291

Anti-inflammatory and antirheumatic products, non-steroids

303

1.30

1.31

1.0

681.36

702.24

ng/l

0.13

205

Malignant neoplasm of head and neck

245

0.57

1.31

1.0

636.14

708.03

ng/l

—

148

Other disorders of bladder

292

1.41

1.30

1.0

672.77

706.84

ng/l

0.26

187

Appendectomy

141

1605

0.84

1.30

1.0

757.26

754.39

ng/l

0.03

108

1100

Dilated cardiomyopathy

331

0.63

1.29

1.0

747.33

707.60

ng/l

0.16

221

Abnormalities of heart beat

111

890

1.22

1.29

1.0

801.10

711.57

ng/l

1.11

585

Ulcer of lower limb, not elsewhere classified

378

0.66

1.28

1.0

940.35

690.36

ng/l

1.11

244

Intestinal infectious diseases

291

1951

1.13

1.28

1.0

755.07

746.39

ng/l

0.12

210

1321

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

484

0.70

1.27

1.0

940.79

738.18

ng/l

1.93

308

Chronic diseases of tonsils and adenoids

190

1396

0.86

1.26

1.0

750.48

748.47

ng/l

0.02

140

972

Endometriosis

430

1.26

1.0

744.04

723.12

ng/l

0.16

288

Keratitis

103

839

1.23

1.26

1.0

775.07

729.71

ng/l

0.43

577

Functional dyspepsia

660

1.26

1.25

1.0

753.31

714.86

ng/l

0.39

438

ILD, hospital admissions

412

0.68

1.25

1.0

857.25

689.67

ng/l

1.22

264

Aortic valve malfunction, age under 60 years

242

0.58

1.25

1.0

922.11

767.22

ng/l

—

172

Benign mammary dysplasia

320

1.38

1.24

1.0

845.45

720.18

ng/l

0.93

218

Malignant neoplasm of breast, including Hilmo

104

824

0.82

1.24

1.0

732.30

740.52

ng/l

0.06

573

Malignant neoplasm of breast, HER2-negative, including Hilmo

104

824

0.82

1.24

1.0

732.30

740.52

ng/l

0.06

573

Covid-19 suspected case

380

1.34

1.24

1.0

782.95

770.91

ng/l

0.07

265

Benign neoplasm: Sigmoid colon

555

1.28

1.24

1.0

674.91

715.48

ng/l

0.25

368

Postpartum hemorraghe, parous women as controls

248

0.62

1.24

1.0

794.58

792.61

ng/l

0.00

189

Ulcer of oesophagus

171

1.53

1.23

1.0

735.54

685.32

ng/l

0.25

101

Vitamin deficiency, wide

1.77

1.23

1.0

979.10

675.88

ng/l

—

Vitamin deficiency

1.77

1.23

1.0

979.10

675.88

ng/l

—

Fracture of shoulder and upper arm

111

913

1.22

1.23

1.0

747.04

712.44

ng/l

0.33

608

Other symptoms and signs involving the circulatory and respiratory systems

147

1.57

1.22

1.0

907.00

683.54

ng/l

1.12

Chronic kidney disease

827

0.78

1.21

1.0

803.40

713.64

ng/l

0.96

532

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

147

1209

1.18

1.21

1.0

692.22

746.28

ng/l

0.74

102

839

Other diseases of biliary tract

214

0.56

1.21

1.0

729.71

663.22

ng/l

—

137

Special screening examination for neoplasms

1.72

1.21

1.2

1.0

735.18

648.93

ng/l

0.26

Unspecified haematuria

145

1015

1.19

1.20

1.0

736.75

730.05

ng/l

0.07

100

664

Anterior Iridocyclitis

478

1.30

1.20

1.0

867.54

727.81

ng/l

1.43

330

Diaphragmatic hernia

126

1053

1.20

1.0

786.56

711.35

ng/l

0.91

703

Allergic conjunctivitis

152

1258

1.18

1.20

1.0

690.32

750.80

ng/l

0.91

106

874

Left ventricular outflow tract obstruction (LVOTO), broad definition

251

0.60

1.20

1.0

922.11

769.38

ng/l

—

177

Car occupant injured in other and unspecified transport accidents

348

1.35

1.20

1.1

1.0

732.50

755.32

ng/l

0.16

238

Brachial plexus disorders

156

1.54

1.20

1.0

952.15

755.70

ng/l

0.80

110

Primary open-angle glaucoma, strict

744

1.24

1.19

1.0

688.53

686.97

ng/l

0.01

474

Malignant immunoproliferative diseases

2.33

1.19

1.2

1.0

854.33

538.53

ng/l

—

Palmar fascial fibromatosis [Dupuytren]

418

1.32

1.19

1.0

733.72

705.95

ng/l

0.22

280

Arthrosis

249

1199

1.14

1.18

1.0

783.38

723.58

ng/l

1.35

169

832

COPD differential diagnosis

267

1178

1.14

1.18

1.0

792.52

729.66

ng/l

1.24

192

796

ILD differential diagnosis

267

1178

1.14

1.18

1.0

792.52

729.66

ng/l

1.24

192

796

COPD/asthma related infections

340

1522

1.12

1.18

1.0

769.29

737.25

ng/l

0.59

231

1049

COPD/asthma/ILD related infections

340

1522

1.12

1.18

1.0

769.29

737.25

ng/l

0.59

231

1049

Heart failure, not strict

230

1779

0.88

1.18

1.0

737.11

736.43

ng/l

0.01

161

1220

Benign neoplasm: Colon, unspecified

761

0.77

1.18

1.0

793.14

712.62

ng/l

0.70

504

Tinnitus

613

1.26

1.17

1.0

800.31

722.59

ng/l

0.80

428

Congenital iodine-deficiency syndrome/hypothyroidism

2.01

1.16

1.0

693.20

608.96

ng/l

—

Neuroendocrine tumor and carcinoma of small intestine

0.00

1.16

0.0

1.0

—

575.91

—

Portal vein thrombosis

0.00

1.16

0.0

1.0

—

611.44

—

Drug-induced osteoporosis

0.00

1.16

0.0

1.0

—

664.00

—

Acute nasopharyngitis (common cold)

238

1.42

1.16

1.0

832.52

800.89

ng/l

0.16

169

Nephropathy related operations

321

0.65

1.15

1.0

607.86

734.36

ng/l

1.05

220

Frostbite

2.52

1.15

1.0

547.40

531.90

ng/l

—

Glaucoma suspect

125

1050

1.19

1.14

1.0

796.57

714.95

ng/l

0.91

693

Insulin, fast-acting

107

885

1.21

1.14

1.0

811.04

732.82

ng/l

1.01

599

Diarrhoea and gastroenteritis of presumed infectious origin

322

1901

1.12

1.14

1.0

786.12

742.92

ng/l

0.89

230

1287

Malignant neoplasm of heart, mediastinum and pleura

0.00

1.14

0.0

1.0

—

641.33

—

Other follicular disorders

126

1.59

1.14

1.0

756.25

747.59

ng/l

0.03

Other noninflammatory disorders of vagina

142

1.55

1.14

1.0

743.79

682.99

ng/l

0.23

Oxicams

301

1.28

1.14

1.0

831.12

697.90

ng/l

1.51

204

Other arthrosis

196

1179

1.15

1.13

1.0

778.47

719.24

ng/l

1.05

138

819

Achilles tendinitis

241

1.41

1.13

1.0

824.57

713.96

ng/l

0.62

181

Cerebral aneurysm, nonruptured

216

1.44

1.13

1.0

545.88

753.80

ng/l

1.76

143

Disorders of lacrimal system

139

1177

1.18

1.13

1.0

737.73

726.59

ng/l

0.10

796

Deviated nasal septum

114

950

1.20

1.13

1.1

1.0

768.33

742.84

ng/l

0.24

648

Pollen allergy

205

1.45

1.13

1.0

820.50

815.46

ng/l

0.03

141

Asthma (only as main-diagnosis), excluding more controls

226

1132

1.14

1.12

1.0

808.47

730.83

ng/l

1.52

146

766

Neuralgia and neuritis, unspecified

103

1.66

1.12

1.0

634.17

682.28

ng/l

0.31

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

171

1434

1.16

1.12

1.1

1.0

815.96

745.25

ng/l

1.22

135

980

Inflammatory diseases of female pelvic organs

156

981

1.17

1.11

1.0

781.89

734.78

ng/l

0.59

115

676

ILD medications: immunosuppressive drugs

160

1724

0.86

1.11

1.0

807.57

730.79

ng/l

1.18

116

1197

Other diseases of liver

459

0.72

1.11

1.0

934.70

737.40

ng/l

1.05

317

Other diseases of blood and blood-forming organs, wide

585

0.75

1.11

1.0

689.42

713.04

ng/l

0.16

395

Examination and encounter for administrative purposes

1.79

1.11

1.0

805.50

634.43

ng/l

—

Disorders of breast

131

1006

1.18

1.10

1.0

820.86

732.05

ng/l

1.36

696

Other condition

302

1.36

1.10

1.0

809.19

736.93

ng/l

0.37

204

Malignant neoplasm of breast, ER-negative, including Hilmo

621

0.77

1.10

1.0

726.72

714.87

ng/l

0.06

416

Acute and subacute iridocyclitis

450

1.29

1.10

1.1

1.0

880.60

723.81

ng/l

1.62

314

Trochanteric bursitis

328

1.34

1.10

1.0

782.26

682.48

ng/l

0.86

221

Status post-ami

660

0.80

1.10

1.0

727.18

702.76

ng/l

0.16

430

Insulin, fast-acting or short human

108

899

1.20

1.09

1.0

812.85

738.23

ng/l

0.96

610

Acute gastritis

168

1.49

1.09

1.0

834.37

712.06

ng/l

0.53

Erysipelas

250

1692

1.13

1.09

1.0

785.01

743.14

ng/l

0.69

158

1159

Small fibre neuropathy

1.83

1.09

1.1

1.0

759.86

615.56

ng/l

—

Insulin, fast-acting (human)

243

1.40

1.09

1.0

926.83

760.19

ng/l

1.03

163

Other congenital malformations

201

1.44

1.09

1.0

841.77

746.20

ng/l

0.68

129

Abnormal findings on examination of blood, without diagnosis

158

1248

1.16

1.09

1.0

772.08

727.13

ng/l

0.65

106

836

Spondylolisthesis/Spondylolysis

442

1.29

1.09

1.0

812.72

694.09

ng/l

1.10

315

Type 1 diabetes, wide definition, subgroup 1

398

1.31

1.08

1.0

892.81

762.58

ng/l

1.29

273

Other maltreatment syndromes

2.19

1.08

1.0

983.86

676.41

ng/l

—

Myocardial infarction, without ST-elevation

102

1116

0.83

1.08

1.0

720.12

699.55

ng/l

0.16

728

Liquid cancers, helper endpoint

108

1125

0.84

1.07

1.0

810.37

718.98

ng/l

1.20

740

L02BB Anti-androgens

255

0.63

1.07

1.0

794.50

639.39

ng/l

—

156

Other specified and unspecified retinal disorders

1.76

1.07

1.0

797.67

641.20

ng/l

—

Pulmonary heart disease, diseases of pulmonary circulation

893

0.81

1.06

1.0

719.74

720.47

ng/l

0.00

587

Other and unspecified nerve root and plexus disorders, also in other diseases

488

1.27

1.06

1.0

759.89

740.07

ng/l

0.14

332

Acute pharyngitis

234

1.40

1.06

1.0

629.54

773.81

ng/l

2.26

160

Hypertensive heart and/or renal disease

635

0.80

1.06

1.0

731.84

712.97

ng/l

0.12

408

Diseases of pulp and periapical tissues, including avohilmo

332

1548

1.11

1.06

1.0

740.06

731.64

ng/l

0.13

227

1042

Disorders of conjunctiva

242

1724

1.13

1.05

1.0

719.21

749.59

ng/l

0.48

169

1187

Ganglion

480

1.27

1.05

1.0

641.41

724.15

ng/l

1.05

340

Panniculitis affecting regions of neck and back

1.80

1.04

1.1

1.0

951.33

626.38

ng/l

—

Sudden idiopathic hearing loss

253

0.63

1.04

1.1

1.0

549.60

714.29

ng/l

—

168

Other diseases of oesophagus

220

1.41

1.04

1.0

762.55

702.88

ng/l

0.36

129

Myalgia

516

1.26

1.04

1.0

832.38

719.91

ng/l

1.06

359

Supervision of normal pregnancy

153

0.63

1.04

1.0

924.33

819.46

ng/l

0.34

125

Thyrotoxicosis with diffuse goitre

289

0.66

1.04

1.0

575.00

742.73

ng/l

1.19

203

Mouth breathing

131

1115

1.17

1.04

1.0

804.84

742.09

ng/l

0.71

769

Noninfective enteritis and colitis

132

1124

1.17

1.04

1.0

825.98

732.27

ng/l

1.44

765

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

824

1.20

1.03

1.0

755.45

720.85

ng/l

0.34

563

Fracture of lower leg, including ankle

176

1520

1.15

1.03

1.0

790.17

736.74

ng/l

0.80

121

1039

Dermatophytosis

347

0.69

1.02

1.0

793.44

727.49

ng/l

0.41

235

Benign neoplasm: Colon

201

1690

1.14

1.02

1.0

725.80

726.47

ng/l

0.01

137

1126

Meniscus derangement

201

1189

1.14

1.02

1.0

744.75

723.37

ng/l

0.27

147

826

Enlarged lymph nodes

324

1.33

1.02

1.0

791.00

740.74

ng/l

0.35

230

Malignant neoplasm of breast, HER-negative

554

0.76

1.01

1.0

755.44

701.98

ng/l

0.29

360

Other retinal disorders

218

1502

1.13

1.01

1.0

752.19

727.06

ng/l

0.30

146

991

Benign neoplasms

300

1487

1.11

1.00

1.0

744.96

747.44

ng/l

0.03

215

1015

Myocardial infarction, unclassifiable

523

0.77

1.00

1.0

659.25

689.69

ng/l

0.17

324

Other infectious diseases

197

1.42

0.99

1.0

796.00

685.63

ng/l

0.51

123

Viral hepatitis

115

1.57

0.99

1.1

1.0

767.55

797.03

ng/l

0.12

Fentanyl

261

0.65

0.99

1.0

868.60

680.56

ng/l

—

165

Asthma (only as main-diagnosis)

229

1175

1.13

0.99

1.0

807.54

729.37

ng/l

1.56

147

794

Alcoholic gastritis

2.18

0.98

1.2

1.0

907.60

609.82

ng/l

—

Pulmonary eosinophilia, not elsewhere classified

0.00

0.98

0.0

1.0

—

656.80

—

Acquired absence of organs, not elsewhere classified

0.00

0.98

0.0

1.0

—

519.71

—

Mesothelioma

0.00

0.97

0.0

1.0

—

613.50

—

Universal erythroderma, KELA reimbursement

0.00

0.97

0.0

1.0

—

583.37

—

Conjunctivitis

211

1561

1.13

0.97

1.0

716.66

748.00

ng/l

0.45

145

1084

Inflammation of lacrimal passages (acute and unspecified)

0.00

0.97

0.0

1.0

—

559.71

—

Benign neoplasm: Stomach

249

1.37

0.97

1.1

1.0

782.26

690.72

ng/l

0.53

156

Chronic gastritis

784

1.20

0.97

1.0

825.04

702.76

ng/l

1.65

506

Other sexually transmitted chlamydial diseases

1.95

0.97

1.0

995.43

902.40

ng/l

—

Soft tissue disorders related to use, overuse and pressure

748

1.20

0.96

1.0

751.72

722.88

ng/l

0.29

509

Other mycoses, not elsewhere classified/unspecified

0.00

0.96

0.0

1.0

—

585.50

—

Subarachnoid haemorrhage

258

1.36

0.96

1.0

623.50

730.13

ng/l

0.61

164

L02BA Anti-estrogens

377

0.71

0.96

1.1

1.0

772.78

728.07

ng/l

0.23

255

Diseases of liver

969

0.82

0.96

1.0

781.34

727.94

ng/l

0.41

663

Cerebral palsy and other paralytic syndromes

241

1.37

0.96

1.0

830.88

707.99

ng/l

0.73

149

Ischemic heart diseases

309

1678

1.11

0.96

1.0

752.49

749.96

ng/l

0.03

203

1178

Infections of genitourinary tract in pregnancy

149

1.48

0.95

1.0

779.81

723.89

ng/l

0.22

109

Asthma (diagnoses ohter than nonallergic)

264

1969

1.11

0.95

1.0

801.39

735.32

ng/l

1.38

182

1346

Pleural plaque

282

0.67

0.94

1.0

506.36

641.08

ng/l

0.86

168

Polyarthrosis

586

1.22

0.94

1.0

797.44

689.20

ng/l

1.26

386

Hypothermia

1.90

0.94

1.0

817.00

528.65

ng/l

—

Other infectious diseases

166

1.45

0.94

1.0

808.16

680.82

ng/l

0.52

101

ILD, hospital admissions 1, main diag only

375

0.72

0.94

1.0

857.25

689.38

ng/l

1.22

241

Other hammer toe(s) (acquired)

483

0.76

0.94

1.0

881.30

660.18

ng/l

1.67

317

Alcohol abuse counselling and surveillance

2.23

0.93

1.2

1.0

931.67

564.13

ng/l

—

Diseases of arteries, arterioles and capillaries

191

1594

0.88

0.93

1.0

749.35

717.72

ng/l

0.47

129

1047

Malignant melanoma of skin

328

0.70

0.93

1.0

480.36

715.68

ng/l

3.11

205

L04AA Selective immunosuppressants

534

0.77

0.93

1.0

734.52

756.76

ng/l

0.11

370

Superficial injury of thorax

338

1.30

0.93

1.0

851.65

739.52

ng/l

0.85

225

Degenerative macular diseases

312

1.32

0.93

1.0

654.72

704.25

ng/l

0.37

192

Other and unspecified effects of external causes

534

1.24

0.92

1.0

792.98

739.48

ng/l

0.49

371

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

688

1.21

0.92

1.0

728.65

738.59

ng/l

0.06

468

Excluding asthma or asthma-COPD overlap

264

1187

1.11

0.92

1.0

793.58

729.26

ng/l

1.27

190

800

Other and unspecified tonsillitis

448

1.24

0.92

1.1

1.0

970.55

808.13

ng/l

1.53

319

Peripheral artery operations in Hilmo

338

0.71

0.91

1.0

833.25

660.47

ng/l

0.99

207

Deforming dorsopathies

653

1.21

0.91

1.0

749.43

703.55

ng/l

0.40

465

Follow-up examination after treatment for malignant neoplasms

176

1.42

0.90

1.1

1.0

661.12

636.93

ng/l

0.12

122

Haemorrhage from respiratory passages

116

895

1.17

0.90

1.0

735.63

695.39

ng/l

0.50

579

ILD medications

304

1814

0.91

0.90

1.0

820.19

727.94

ng/l

2.89

211

1246

Maltreatment syndromes

1.91

0.88

1.1

1.0

921.50

792.69

ng/l

—

Nasal polyp

529

1.23

0.88

1.0

699.76

726.07

ng/l

0.17

356

Polyarthropathies

206

1198

1.12

0.88

1.0

803.54

722.98

ng/l

1.51

142

831

Gout, FINNGEN

879

0.83

0.87

1.0

716.15

712.30

ng/l

0.02

572

Ulcerative proctitis

103

1.56

0.87

1.0

732.60

697.98

ng/l

—

Urticaria

611

1.21

0.87

1.0

787.50

737.24

ng/l

0.36

426

Sequelae of injuries of upper limb

220

1.37

0.87

1.1

1.0

633.18

738.06

ng/l

0.95

145

Diagnoses used for exclusion with ILD

657

1.20

0.87

1.0

747.18

727.94

ng/l

0.15

438

Disorders of refraction and accommodation

510

1.23

0.86

1.0

762.00

750.78

ng/l

0.07

357

Divergent concomitant strabismus

136

1.47

0.86

1.1

1.0

747.75

759.53

ng/l

0.04

Collagenous colitis

212

1.37

0.86

1.0

768.73

702.25

ng/l

0.31

138

Use of antiglaucoma preparations and miotics

178

1.41

0.86

1.0

523.19

658.04

ng/l

1.28

107

Other disorders of bone

423

1.25

0.85

1.0

860.41

742.80

ng/l

1.21

293

Second line medication for Crohn's disease

139

1588

0.87

0.85

1.0

800.34

740.37

ng/l

0.78

101

1083

Cellulitis

522

1.23

0.85

1.0

737.27

732.73

ng/l

0.03

354

DVT of lower extremities

526

0.78

0.85

1.0

787.08

712.51

ng/l

0.58

355

Gastroduodenal ulcer

693

1.20

0.85

1.0

689.87

706.37

ng/l

0.11

449

Antihypertensive medication - note that there are other indications

133

610

1.16

0.84

1.0

808.64

761.90

ng/l

0.53

457

Disease of hard tissues of teeth, NOS

184

852

1.13

0.84

1.0

798.27

713.97

ng/l

1.52

129

571

Biological medication for rheuma

321

0.72

0.84

1.0

803.50

774.57

ng/l

0.12

227

525

0.79

0.84

1.0

705.93

677.27

ng/l

0.13

312

L04AX Other immunosuppressants

136

1553

0.87

0.83

1.0

797.01

738.52

ng/l

0.73

1060

Other disorders of veins

102

1183

0.86

0.83

1.0

773.13

734.22

ng/l

0.41

825

Viral warts

423

0.76

0.83

1.0

773.24

739.03

ng/l

0.10

293

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

129

1.48

0.83

1.0

764.36

626.53

ng/l

0.87

Bell's palsy

283

1.31

0.83

1.0

718.27

729.73

ng/l

0.06

191

Polypectomy (DHB20)

171

1.41

0.83

1.0

728.33

696.35

ng/l

0.11

109

Other predominantly sexually transmitted diseases, not elsewhere classified

205

1.37

0.83

1.1

1.0

835.30

801.61

ng/l

0.11

148

Polymyalgia rheumatica

354

0.73

0.82

1.0

636.72

695.30

ng/l

0.29

217

Acute appendicitis, with complications

512

0.78

0.82

1.1

1.0

704.71

731.44

ng/l

0.16

344

Female infertility, cervical, vaginal, other or unspecified origin

349

0.78

0.82

1.0

816.44

743.11

ng/l

0.49

245

Superficial injury of wrist and hand

363

1.27

0.82

1.0

798.38

780.24

ng/l

0.08

249

Speech therapy

680

1.19

0.82

1.0

774.45

714.22

ng/l

0.58

452

Injuries to the knee and lower leg

371

1895

1.09

0.82

1.0

761.50

741.71

ng/l

0.37

258

1289

Haemorrhage in early pregnancy

467

1.23

0.81

1.1

1.0

704.76

732.62

ng/l

0.17

337

Acute renal failure

611

0.80

0.81

1.0

768.94

723.29

ng/l

0.29

401

Non-Hodgkin lymphoma, all, including Hilmo

421

0.76

0.81

1.0

752.62

730.09

ng/l

0.09

262

Dental caries

566

1.21

0.81

1.0

696.10

736.79

ng/l

0.36

396

Myocardial infarction

151

1204

0.88

0.81

1.0

722.59

722.80

ng/l

0.00

814

Primary open-angle glaucoma

107

890

1.16

0.81

1.0

680.06

689.88

ng/l

0.07

568

Pulmonary heart disease

818

0.83

0.80

1.0

713.53

713.95

ng/l

0.00

542

Heterophoria

130

1.46

0.80

1.0

1076.00

729.82

ng/l

—

Antenatal screening

167

0.71

0.80

1.0

802.80

818.47

ng/l

0.05

135

Other viral diseases

658

1.19

0.80

1.0

831.90

747.05

ng/l

0.85

461

Injuries to the ankle and foot

155

1555

0.89

0.80

1.0

807.59

754.68

ng/l

0.80

114

1077

Pulmonary embolism

817

0.83

0.80

1.0

713.53

712.34

ng/l

0.01

541

Injury of muscle and tendon at lower leg level

397

0.75

0.80

1.0

690.73

720.59

ng/l

0.16

273

Orchitis and epididymitis

198

1.37

0.80

1.0

918.32

767.47

ng/l

0.91

129

Leiomyosarcoma, including Hilmo

0.00

0.79

0.0

1.0

—

606.33

—

Melanoma of uvea

0.00

0.79

0.0

1.0

—

543.79

—

Exposure to other specified factors

222

1840

1.11

0.79

1.0

800.68

744.40

ng/l

1.14

162

1263

Irregular menses

107

727

1.16

0.79

1.0

789.08

742.52

ng/l

0.45

523

Carcinoid syndrome

0.00

0.79

0.0

1.0

—

555.60

—

Type 1 diabetes, wide definition, subgroup 2

0.00

0.79

0.0

1.0

—

475.69

—

Accidental poisoning by and exposure to alcohol

0.00

0.79

0.0

1.0

—

475.00

—

Varus deformity, not elsewhere classified

0.00

0.79

0.0

1.0

—

467.50

—

Dissociative [conversion] disorders

1.82

0.79

1.0

976.67

560.00

ng/l

—

Corneal ulcer

401

1.25

0.79

1.0

723.06

748.23

ng/l

0.15

278

Other systemic involvement of connective tissue (FG)

687

0.82

0.79

1.0

674.20

693.34

ng/l

0.12

450

Other and unspecified haemorrhagic conditions

0.00

0.78

0.0

1.0

—

514.76

—

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

837

0.84

0.78

1.0

861.08

742.74

ng/l

1.74

590

Glucagon-like peptide-1 (GLP-1) analogues

837

0.84

0.78

1.0

861.08

742.74

ng/l

1.74

590

Other congenital malformations of skin

131

1.45

0.78

1.0

770.29

751.90

ng/l

0.07

Other pulmonary diagnosis

261

1187

1.10

0.78

1.0

786.73

729.26

ng/l

1.06

187

800

Raynaud syndrome

165

1.40

0.77

1.0

787.41

704.51

ng/l

0.49

101

Myeloproliferative diseases

222

0.67

0.77

1.0

888.80

694.67

ng/l

—

142

Sub-endpoint used in defining T1D endpoints

584

1.20

0.76

1.0

893.12

739.95

ng/l

1.53

392

UC patients in KELA-register (code 208), prior to 1994

107

1.50

0.76

1.1

1.0

801.89

689.90

ng/l

—

Hydrocele

270

1.30

0.75

1.0

780.09

766.87

ng/l

0.08

175

Appendicitis, broad definition

185

1860

0.90

0.75

1.1

1.0

832.76

748.26

ng/l

1.43

142

1293

Type 1 diabetes, wide definition

422

1.23

0.74

1.0

892.81

759.77

ng/l

1.33

285

Fitting and adjustment of other devices

122

964

1.14

0.74

1.0

737.93

679.52

ng/l

0.73

600

Erosion of teeth , including avohilmo

450

1.22

0.74

1.0

769.59

770.38

ng/l

0.00

308

Conduction disorders

815

0.85

0.74

1.0

695.73

714.60

ng/l

0.19

528

Postpartum hemorraghe, all women as controls

251

0.71

0.74

1.0

794.58

807.01

ng/l

0.03

192

Systemic connective tissue disorders

918

0.85

0.74

1.0

733.44

707.91

ng/l

0.19

599

Acetic acid derivatives and related substances

302

1.20

0.73

1.0

798.32

702.24

ng/l

1.01

205

Herpesviral [herpes simplex] infections

243

0.70

0.73

1.0

768.78

716.61

ng/l

—

163

Asthma, hospital admissions , main diagnosis only

239

1920

1.10

0.73

1.0

809.62

738.06

ng/l

1.47

154

1319

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma, including Hilmo

2.02

0.73

1.2

1.0

850.20

548.37

ng/l

—

Coxibs

302

1.20

0.73

1.0

755.27

702.24

ng/l

0.40

205

Iridocyclitis

533

1.20

0.73

1.0

862.20

740.16

ng/l

1.21

363

Open wound of wrist and hand

120

1029

1.14

0.72

1.0

704.02

760.39

ng/l

0.95

706

Ischaemic heart disease, wide definition

296

1685

1.09

0.72

1.0

736.74

746.90

ng/l

0.14

197

1169

Asthma, unspecified (mode)

169

1139

1.12

0.72

1.0

806.66

724.62

ng/l

1.27

118

770

Lateral epicondylitis

317

1.26

0.71

1.0

723.77

727.44

ng/l

0.02

224

Diseases of appendix

188

1875

0.90

0.71

1.1

1.0

831.13

747.18

ng/l

1.44

144

1303

Disorder of lipoprotein metabolism, unspecified

381

1.24

0.70

1.0

735.47

732.92

ng/l

0.02

241

Lung diseases due to external agents

327

1.26

0.70

1.0

713.13

683.74

ng/l

0.17

209

Endometriosis of rectovaginal septum and vagina

143

1.40

0.70

1.1

1.0

660.82

655.26

ng/l

0.02

Pedal cyclist injured in transport accident

472

1.21

0.69

1.0

819.30

742.19

ng/l

0.63

325

Carpal tunnel syndrome

196

1564

1.10

0.69

1.0

809.80

727.40

ng/l

1.57

147

1069

Other diseases of the digestive system

860

1.15

0.69

1.0

763.05

718.51

ng/l

0.46

565

Caries of enamel

227

1794

0.91

0.69

1.0

778.72

752.72

ng/l

0.42

148

1264

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

332

0.76

0.69

1.0

887.42

745.68

ng/l

0.71

223

Other specified and unspecified personality disorders

152

1.38

0.69

1.0

776.00

812.88

ng/l

0.16

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

204

1.33

0.68

1.0

968.60

716.66

ng/l

0.91

129

DVT of lower extremities and pulmonary embolism

105

1194

0.87

0.68

1.0

746.40

714.61

ng/l

0.34

790

Other pleural conditions

262

0.72

0.68

1.1

1.0

749.00

660.27

ng/l

—

157

Nummular dermatitis

213

1.32

0.68

1.0

883.84

688.33

ng/l

1.25

140

Gonarthrosis [arthrosis of knee](FG)

281

1503

1.09

0.68

1.0

758.43

728.83

ng/l

0.48

196

1040

Familial hypercholesterolemia

447

1.21

0.67

1.0

667.50

725.79

ng/l

0.53

284

Deep endometriosis

153

1.37

0.67

1.0

660.82

767.09

ng/l

0.44

100

Sulfonylureas

843

0.87

0.66

1.0

723.81

695.74

ng/l

0.23

536

Other symptoms and signs involving the urinary system

258

1.28

0.66

1.0

770.15

700.78

ng/l

0.51

170

Asthma, unspecified (mode), excluding more controls

164

1103

1.11

0.66

1.0

815.01

725.17

ng/l

1.44

116

747

Other and unspecified urticaria

393

1.22

0.66

1.0

812.42

744.24

ng/l

0.40

266

D07AA Corticosteroids, weak (group I)

237

0.72

0.66

1.2

1.0

862.17

741.88

ng/l

0.54

157

Burns and corrosions

283

0.74

0.66

1.1

1.0

690.29

759.62

ng/l

0.39

189

Diseases of external ear

100

874

1.14

0.66

1.0

748.35

735.75

ng/l

0.10

595

Hernia of abdominal wall

116

1311

0.88

0.65

1.0

740.53

736.40

ng/l

0.04

884

Other/unspecified enthesopathies of lower limb, excluding foot

128

1.41

0.65

1.0

982.18

684.23

ng/l

2.10

Allergic contact dermatitis

268

1.27

0.65

1.0

731.96

733.34

ng/l

0.01

181

Opioids

300

1440

1.08

0.65

1.0

809.55

720.56

ng/l

2.66

210

978

ILD, hospital admission 2, with pulmonary infections

259

0.73

0.64

1.0

817.13

686.05

ng/l

—

168

Stomatitis and related lesions

427

0.80

0.64

1.0

737.92

743.78

ng/l

0.03

286

Other and unspecified vascular occlusions

233

1.29

0.64

1.0

696.47

690.88

ng/l

0.03

139

Separation of retinal layers (serosa)

1.48

0.64

1.1

1.0

739.86

746.10

ng/l

—

Other diseases of upper respiratory tract

354

1717

1.07

0.64

1.0

769.48

737.15

ng/l

0.65

246

1158

Inflammatory bowel disease

699

1.16

0.64

1.0

818.80

731.27

ng/l

1.14

492

Seropositive rheumatoid arthritis, strict definition

382

0.78

0.63

1.0

842.35

711.55

ng/l

0.87

252

Corns and callosities

146

1.37

0.63

1.1

1.0

799.55

710.90

ng/l

0.21

Wet age-related macular degeneration

424

0.80

0.63

1.1

1.0

624.60

660.03

ng/l

0.19

253

Seropositive rheumatoid arthritis

739

0.85

0.63

1.0

849.77

718.38

ng/l

1.22

484

Polyp of the female genital tract

428

0.84

0.63

1.0

751.18

723.33

ng/l

0.20

287

Chronic lower respiratory diseases

374

1859

1.07

0.63

1.0

789.47

737.69

ng/l

1.33

264

1271

Chronic ulcer of skin, not elsewhere classified

165

0.67

0.63

1.1

1.0

818.17

670.23

ng/l

—

103

Other viral diseases, not elsewhere classified

439

1.20

0.62

1.0

811.29

752.53

ng/l

0.37

303

Erysipelas

187

1505

1.10

0.62

1.0

774.04

735.53

ng/l

0.51

118

1014

Secondary uncertain malignant neoplasm

392

0.79

0.62

1.0

958.95

727.98

ng/l

1.80

243

Female infertility

353

0.82

0.62

1.0

837.31

742.45

ng/l

0.64

247

Atypical facial pain

104

1.45

0.62

1.0

1055.50

695.37

ng/l

—

Adjustment and management of implanted device

491

0.81

0.62

1.0

678.13

687.72

ng/l

0.07

306

Cholelithiasis

242

1811

0.92

0.62

1.0

741.53

736.94

ng/l

0.05

153

1246

Other bursopathies

336

0.77

0.62

1.0

688.81

699.23

ng/l

0.05

230

Viral warts

188

0.69

0.62

1.0

811.43

739.74

ng/l

—

125

Early onset COPD, excluding more controls

599

0.83

0.62

1.0

832.03

708.18

ng/l

1.33

404

Diseases of middle ear and mastoid

101

938

0.88

0.62

1.0

786.90

724.75

ng/l

0.69

638

Effects of other external causes

1.67

0.61

1.0

1035.80

701.56

ng/l

—

Other sexually transmitted chlamydial diseases

1.67

0.61

1.0

1124.00

870.55

ng/l

—

Gonarthrosis

228

1191

1.09

0.61

1.0

752.61

720.80

ng/l

0.46

157

825

Tumor necrosis factor alpha inhibitors

279

0.75

0.61

1.0

823.44

784.12

ng/l

0.15

196

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

309

1981

1.08

0.61

1.0

746.82

749.37

ng/l

0.03

227

1346

Prepatellar bursitis

113

1.42

0.61

1.0

863.10

657.27

ng/l

—

Adhesive capsulitis of shoulder

434

1.20

0.61

1.0

792.13

694.72

ng/l

0.61

305

Codeine

286

1439

1.08

0.60

1.0

786.27

719.67

ng/l

1.92

197

977

Other congenital malformations of upper alimentary tract

0.00

0.60

0.0

1.0

—

450.91

—

Malignant neoplasm of other and unspecified urinary organs, including Hilmo

0.00

0.60

0.0

1.0

—

547.36

—

Corticotropin deficiency

0.00

0.60

0.0

1.0

—

528.91

—

Diabetic retinopathy

535

1.14

0.60

1.0

801.41

759.26

ng/l

0.33

361

Glaucoma secondary to eye inflammation

0.00

0.60

0.0

1.0

—

526.55

—

Primary adrenocortical insufficiency

0.00

0.60

0.0

1.0

—

531.64

—

Certolizumab pegol

0.00

0.60

0.0

1.0

—

495.62

—

Tooth agenesis EXCLUDE clefts and syndromes

0.00

0.60

0.0

1.0

—

617.00

—

Acute drug-induced interstitial lung disorder

0.00

0.60

0.0

1.0

—

566.46

—

Aspergillosis

0.00

0.60

0.0

1.0

—

544.92

—

Malignant neoplasm of bone and articular cartilage of limbs, including Hilmo

0.00

0.60

0.0

1.0

—

576.75

—

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

355

0.79

0.60

1.0

702.94

694.29

ng/l

0.04

208

Polyarthritis, unspecified

1.50

0.60

1.0

762.33

625.43

ng/l

—

Mycoses

255

2051

1.08

0.59

1.0

801.46

740.85

ng/l

1.15

171

1412

Cardiomyopathies, Secondary/extrinsic

0.00

0.59

0.0

1.0

—

511.36

—

Osteitis due to dental implant

0.00

0.59

0.0

1.0

—

582.79

—

Malignant neoplasm of other and unspecified major salivary glands, including Hilmo

0.00

0.59

0.0

1.0

—

611.38

—

Other predominantly sexually transmitted diseases, not elsewhere classified

227

1.28

0.59

1.1

1.0

850.58

806.26

ng/l

0.16

162

Ventral hernia

640

0.84

0.59

1.1

1.0

706.88

731.44

ng/l

0.20

430

Urticaria and erythema

788

1.14

0.59

1.0

797.47

727.09

ng/l

0.69

550

Gastric ulcer

463

1.19

0.59

1.0

677.30

693.02

ng/l

0.08

287

GI-bleeding

854

1.14

0.59

1.0

762.27

713.45

ng/l

0.50

561

Nonsuppurative otitis media

279

0.77

0.59

1.0

685.30

740.48

ng/l

0.33

180

Varicose veins

184

1521

0.91

0.59

1.0

769.53

720.98

ng/l

0.66

112

1047

Other systemic involvement of connective tissue

682

0.85

0.58

1.0

688.33

698.47

ng/l

0.06

450

Complications of medical and surgical care

230

1950

1.08

0.58

1.0

794.92

732.82

ng/l

1.24

156

1329

Combined immunodeficiencies

0.00

0.58

0.0

1.0

—

542.83

—

Dissocial personality disorder

0.00

0.58

0.0

1.0

—

870.25

—

Other/unspecified seropositive rheumatoid arthritis

724

0.86

0.58

1.0

851.29

704.64

ng/l

1.40

478

Spondylopathies (FG)

282

1.24

0.58

1.0

786.52

738.55

ng/l

0.18

196

Other necrotizing vasculopathies (FG)

149

1.35

0.57

1.0

661.38

672.94

ng/l

0.06

Atopic dermatitis, strict definition

410

1.19

0.57

1.1

1.0

880.77

758.50

ng/l

1.13

287

Diseases of the digestive system

136

1220

1.11

0.57

1.0

768.30

705.80

ng/l

1.02

805

Mycoses

669

0.85

0.57

1.0

814.26

723.22

ng/l

0.76

448

Demyelinating diseases of the central nervous system

132

1.37

0.57

1.2

1.0

815.08

749.85

ng/l

0.21

Noninfectious colitis NAS

283

1.24

0.56

1.0

834.07

728.71

ng/l

0.59

185

Dentofacial anomalies [including malocclusion]

154

1361

0.91

0.56

1.0

770.58

752.29

ng/l

0.17

103

970

Benign neoplasm of breast

252

0.75

0.56

1.0

859.57

732.43

ng/l

0.44

171

Paralytic ileus and intestinal obstruction

689

1.15

0.56

1.0

771.76

703.02

ng/l

0.61

456

Postprocedural musculoskeletal disorders, not elsewhere classified

185

1.30

0.56

1.1

1.0

777.91

682.29

ng/l

0.55

112

Misadventures to patients during surgical and medical care

347

1.21

0.56

1.0

731.00

713.21

ng/l

0.10

229

Corneal degeneration

1.63

0.55

1.0

870.50

629.77

ng/l

—

Diabetic nephropathy, excluding more controls

255

1.23

0.55

1.0

846.57

749.76

ng/l

0.59

168

Visual impairment including blindness (binocular or monocular)

124

1.37

0.55

1.0

947.42

676.71

ng/l

0.78

Malignant neoplasm of bladder

183

0.71

0.55

1.0

582.50

625.98

ng/l

—

106

Hydronephrosis

285

0.77

0.55

1.0

655.69

673.09

ng/l

0.10

182

Dermatitis due to substances taken internally

107

1.40

0.55

1.1

1.0

729.70

696.31

ng/l

—

Cholelithiasis, broad definition with cholecystitis

254

1840

0.93

0.55

1.0

746.97

735.42

ng/l

0.14

158

1268

Overexertion and strenuous or repetitive movements

221

1.27

0.55

1.0

788.62

751.77

ng/l

0.15

145

Infections of the skin and subcutaneous tissue

160

1444

1.10

0.55

1.0

752.42

748.13

ng/l

0.04

110

987

Other infective otitis externa

133

1.36

0.55

1.0

776.92

719.09

ng/l

0.20

Obstructed labour due to maternal pelvic abnormality

348

1.21

0.54

1.0

773.09

766.01

ng/l

0.03

250

Ankylosing spondylitis

177

1.30

0.54

1.0

893.80

719.87

ng/l

0.64

131

Acne vulgaris

1.58

0.54

1.2

1.0

880.33

845.81

ng/l

—

Other abnormal findings of blood chemistry

1.42

0.54

1.0

698.00

666.58

ng/l

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

190

1847

0.92

0.54

1.0

750.25

728.77

ng/l

0.27

144

1232

Secondary hypertension

175

1.30

0.54

1.1

1.0

769.19

742.25

ng/l

0.11

121

Streptococcal septicaemia

205

0.73

0.54

1.0

588.40

678.65

ng/l

—

127

Open wound of forearm

182

0.71

0.54

1.0

819.00

734.66

ng/l

—

117

ILD, hospital admissions 3, with pneumonia sepsis

216

0.74

0.53

1.0

792.60

666.03

ng/l

—

131

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

1.49

0.53

1.1

1.0

720.00

671.80

ng/l

—

Benign neoplasm of middle ear and respiratory system

204

0.73

0.52

1.1

1.0

686.00

717.21

ng/l

—

132

Dermatitis and eczema

339

1973

1.06

0.52

1.0

785.12

740.50

ng/l

1.02

235

1351

Injuries to unspecified part of trunk, limb or body region

215

0.74

0.52

1.0

628.00

704.23

ng/l

—

138

Other noninflammatory disorders of uterus, except cervix

404

0.85

0.52

1.0

629.29

721.53

ng/l

0.96

268

Coxarthrosis

186

1129

1.09

0.51

1.0

777.18

713.46

ng/l

1.20

117

779

Ingrowing nail

1.45

0.51

1.0

653.14

747.33

ng/l

—

Arthropod-borne viral fevers and viral haemorrhagic fevers

237

0.76

0.51

1.1

1.0

672.91

733.29

ng/l

0.25

160

Benign neoplasm: Rectum

536

1.16

0.51

1.0

748.90

696.33

ng/l

0.45

353

Procreative management

524

1.15

0.51

1.0

851.81

769.23

ng/l

0.48

374

Diseases of the skin and subcutaneous tissue

319

1500

1.07

0.51

1.0

764.84

729.97

ng/l

0.64

211

1030

Preterm labour and delivery

536

1.16

0.51

1.0

857.55

766.34

ng/l

0.68

387

Haemorrhoids and perianal venous thrombosis

101

901

1.12

0.51

1.0

834.33

702.11

ng/l

1.35

596

Inflammatory disease of cervix uteri

135

1.34

0.51

1.0

907.31

774.59

ng/l

0.48

Seropositive rheumatoid arthritis, wide

725

0.87

0.51

1.0

849.77

704.08

ng/l

1.43

479

Non-allergic asthma (mode)

486

1.16

0.50

1.0

794.24

689.57

ng/l

0.95

317

Dislocation, sprain and strain of joints and ligaments at neck level

252

1.23

0.49

1.0

672.95

771.83

ng/l

0.80

172

Other medical care

121

1200

0.91

0.49

1.0

697.29

706.17

ng/l

0.07

774

Gestational diabetes (for exclusion)

249

0.81

0.49

1.0

839.52

794.78

ng/l

0.17

192

Biomechanical lesions, not elsewhere classified

110

1.37

0.48

1.0

942.38

689.29

ng/l

—

Otalgia

145

1.31

0.48

1.0

575.71

685.94

ng/l

0.76

Gout

729

0.88

0.48

1.0

716.15

692.58

ng/l

0.16

488

Venous thromboembolism

148

1559

0.92

0.48

1.0

764.11

714.90

ng/l

0.74

1042

Conjunctivitis (acute, non atopic)

575

1.14

0.48

1.0

790.79

738.74

ng/l

0.41

393

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

710

0.87

0.48

1.0

851.29

706.59

ng/l

1.37

473

Other diseases of lip and oral mucosa

120

1089

1.10

0.47

1.0

812.76

735.23

ng/l

1.11

742

Other viral diseases

511

1.15

0.47

1.0

836.13

754.52

ng/l

0.65

358

Other septicaemia

114

993

1.10

0.47

1.0

700.19

708.11

ng/l

0.07

644

Other joint disorders

245

1206

1.07

0.46

1.0

800.07

723.76

ng/l

1.67

167

836

Presence of other devices

661

1.13

0.46

1.1

1.0

714.35

687.66

ng/l

0.19

407

Other peripheral vascular diseases

182

1.27

0.46

1.0

725.00

679.75

ng/l

0.24

110

Ankylosing spondylitis, ICD10

182

1.27

0.46

1.0

893.80

769.49

ng/l

0.41

122

Hypertrophy of breast in women and men

411

1.17

0.46

1.0

799.21

730.71

ng/l

0.43

281

Other diseases of anus and rectum

795

1.12

0.46

1.0

811.62

696.44

ng/l

1.22

529

Female genital prolapse

427

1.13

0.45

1.0

722.45

723.33

ng/l

0.01

287

Hypoparathyroidism

1.43

0.45

1.0

705.80

656.04

ng/l

—

Idiopathic gout

265

0.79

0.45

1.0

755.67

652.52

ng/l

0.44

168

Benign neoplasm: Transverse colon

310

1.20

0.45

1.0

792.79

695.90

ng/l

0.52

204

Problems related to lifestyle

201

1.25

0.44

1.0

736.89

707.83

ng/l

0.13

132

Sarcoidosis

320

1.19

0.44

1.0

772.72

749.24

ng/l

0.12

216

Bronchitis

294

1963

0.94

0.44

1.0

752.50

742.04

ng/l

0.15

203

1340

Other bacterial intestinal infections

544

1.14

0.44

1.0

761.58

722.32

ng/l

0.33

358

Noninflammatory disorders of female genital tract

430

0.89

0.44

1.0

775.60

723.12

ng/l

0.46

288

Decubitus ulcer and pressure area

130

1.31

0.44

1.1

1.0

605.40

632.69

ng/l

—

All influenza (not pneumonia)

330

1.18

0.43

1.1

1.0

651.16

774.16

ng/l

1.06

222

Recurrent aphthous stomatitis , including avohilmo

307

0.81

0.43

1.0

678.18

720.97

ng/l

0.23

194

Primary_lymphoid and hematopoietic malignant neoplasms

693

0.88

0.43

1.1

1.0

813.18

724.82

ng/l

0.69

452

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

120

690

1.10

0.43

1.0

826.97

746.22

ng/l

1.00

509

Heartburn

248

1.21

0.42

1.1

1.0

774.36

718.97

ng/l

0.30

165

Complications of procedures, not elsewhere classified

250

1945

1.06

0.42

1.0

753.97

739.83

ng/l

0.20

171

1342

Melanoma in situ of other and unspecified parts of face

1.57

0.42

1.0

563.40

560.65

ng/l

—

Toxic effects of substances chiefly nonmedicinal as to source

230

1.22

0.42

1.0

751.67

766.42

ng/l

0.06

153

Chronic periodontitis, complicated

187

1727

1.07

0.42

1.0

764.47

737.22

ng/l

0.33

136

1193

Inflammatory bowel disease, strict (require KELA)

462

1.15

0.42

1.0

770.71

754.42

ng/l

0.11

330

Rheumatoid arthritis, including avohilmo

1069

0.91

0.41

1.0

819.32

719.97

ng/l

1.13

716

Non-allergic asthma (mode), excluding more controls

495

1.14

0.41

1.0

794.24

696.97

ng/l

0.86

317

Nail disorders

158

1.27

0.41

1.0

719.08

744.61

ng/l

0.10

102

Other contact dermatitis

158

1.27

0.41

1.1

1.0

955.58

733.64

ng/l

0.98

104

Effects of foreign body entering through natural orifice

566

1.13

0.41

1.0

769.27

760.31

ng/l

0.06

392

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

195

0.77

0.41

1.0

819.44

680.72

ng/l

—

116

Cholecystectomy

197

1817

0.93

0.41

1.0

716.82

735.42

ng/l

0.22

125

1244

Typhoid and paratyphoid fevers

0.00

0.41

0.0

1.0

—

489.71

—

Dermatopolymyositis, unspecified

0.00

0.41

0.0

1.0

—

440.70

—

Toxoplasmosis

0.00

0.41

0.0

1.0

—

455.75

—

Idiopathic hypercalciuria

0.00

0.41

0.0

1.0

—

578.75

—

Deformity of finger(s)

0.00

0.41

0.0

1.0

—

476.30

—

Lower leg

0.00

0.41

0.0

1.0

—

474.67

—

Anuria and oliguria

0.00

0.41

0.0

1.0

—

529.78

—

Increased muscle tone

0.00

0.41

0.0

1.0

—

535.33

—

Panhypopituitarism

1.52

0.41

1.0

642.00

515.95

ng/l

—

Disorders of plasma-protein metabolism, not elsewhere classified

0.00

0.41

0.0

1.0

—

526.33

—

Other specified/unspecified nutritional deficiencies

0.00

0.41

0.0

1.0

—

527.80

—

Melanocytic naevi of lip

0.00

0.41

0.0

1.0

—

532.11

—

Respiratory conditions due to inhalation of chemicals, gases, fumes and vapours

0.00

0.41

0.0

1.0

—

554.43

—

Recurrent and persistent haematuria

0.00

0.41

0.0

1.0

—

496.22

—

ILD medications: nintedanib

0.00

0.41

0.0

1.0

—

436.70

—

Congenital musculoskeletal deformities of head, face, spine and chest

0.00

0.41

0.0

1.0

—

581.11

—

Bus occupant injured in other and unspecified transport accidents

0.00

0.41

0.0

1.0

—

623.20

—

Typhoid and paratyphoid fevers

0.00

0.41

0.0

1.0

—

489.71

—

Other and unspecified disorders of pigmentation

0.00

0.41

0.0

1.0

—

526.33

—

Valgus deformity, not elsewhere classified

0.00

0.41

0.0

1.0

—

546.78

—

Other injuries of spine and trunk, level unspecified

0.00

0.41

0.0

1.0

—

569.00

—

Unspecified human immunodeficiency virus [HIV] disease

0.00

0.41

0.0

1.0

—

647.22

—

Abnormal serum enzyme levels

103

913

1.10

0.41

1.0

776.62

721.46

ng/l

0.63

610

Polycystic ovarian syndrome

0.00

0.41

0.0

1.0

—

556.09

—

ILD medications: prednisolone, methylprednisolone, prednisone

307

1813

0.95

0.41

1.0

827.71

727.94

ng/l

3.35

213

1246

Paget disease

0.00

0.41

0.0

1.0

—

485.78

—

Injury of muscle and tendon at wrist and hand level

314

1.18

0.41

1.0

877.43

742.83

ng/l

1.12

219

Infarction of spleen

0.00

0.41

0.0

1.0

—

507.11

—

Atlantoaxial subluxation

0.00

0.41

0.0

1.0

—

456.67

—

Lichen planus, including avohilmo

501

1.14

0.40

1.0

837.42

722.00

ng/l

0.97

339

Other and unspecified acne

0.00

0.40

0.0

1.0

—

522.80

—

Hepatic failure, not elsewhere classified

1.40

0.40

1.0

729.00

566.21

ng/l

—

Use of glatiramer acetate

0.00

0.40

0.0

1.0

—

593.83

—

Poisoning by narcotics and psychodysleptics [hallucinogens]

0.00

0.40

0.0

1.0

—

668.83

—

AV-block

511

0.87

0.40

1.0

712.34

702.89

ng/l

0.06

319

Acute bronchitis

943

0.90

0.40

1.0

668.47

723.76

ng/l

0.65

618

Disorders of tooth development and eruption

211

0.80

0.40

1.0

864.62

722.83

ng/l

—

148

IBD patients in KELA-register

464

1.14

0.40

1.0

770.71

742.43

ng/l

0.21

327

Fibrosis of liver

0.00

0.40

0.0

1.0

—

543.90

—

Cervical root disorders

0.00

0.40

0.0

1.0

—

578.90

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites

0.00

0.40

0.0

1.0

—

552.00

—

Lung transplant status

0.00

0.40

0.0

1.0

—

526.45

—

Lung transplantation

0.00

0.40

0.0

1.0

—

526.45

—

Malignant neoplasm of parotid gland

0.00

0.40

0.0

1.0

—

590.25

—

Blindness, monocular

0.00

0.40

0.0

1.0

—

510.90

—

Acute mastoiditis

0.00

0.40

0.0

1.0

—

651.87

—

Other injuries of lower limb, level unspecified

0.00

0.40

0.0

1.0

—

410.56

—

Other and unspecified acquired haemolytic anaemias

0.00

0.40

0.0

1.0

—

582.20

—

Benign neoplasm: Short bones of lower limb

0.00

0.40

0.0

1.0

—

498.18

—

Striae atrophicae

0.00

0.40

0.0

1.0

—

642.83

—

Migraine without aura, drug-induced

0.00

0.40

0.0

1.0

—

709.08

—

Use of cabergoline

0.00

0.40

0.0

1.0

—

505.30

—

Assault by sharp object

0.00

0.40

0.0

1.0

—

610.42

—

Temporomandibular joint disorders, including avohilmo

850

1.10

0.40

1.0

733.17

742.26

ng/l

0.07

612

Aplastic and other anaemias

122

1236

0.92

0.40

1.0

731.62

706.63

ng/l

0.21

784

Congenital malformations of great arteries

0.00

0.39

0.0

1.0

—

523.67

—

Ovarian cyst

430

1.11

0.39

1.0

782.57

723.12

ng/l

0.62

288

Preparatory care for dialysis

102

0.68

0.39

1.0

645.00

612.85

ng/l

—

Benign neoplasm: Adrenal gland

214

1.22

0.39

1.0

793.56

694.65

ng/l

0.37

135

Unspecified event, undetermined intent

1.43

0.39

1.0

562.20

588.76

ng/l

—

Granulomatous disorders of skin and subcutaneous tissue

1.43

0.39

1.0

1081.80

673.36

ng/l

—

Complications peculiar to reattachment and amputation

0.00

0.39

0.0

1.0

—

481.80

—

Leiomyosarcoma

0.00

0.39

0.0

1.0

—

517.00

—

Polyarteritis nodosa

0.00

0.39

0.0

1.0

—

512.10

—

Malignant neoplasm of eye and adnexa

0.00

0.39

0.0

1.0

—

543.21

—

Use of entacapone

0.00

0.39

0.0

1.0

—

485.00

—

Intracranial and intraspinal abscess and granuloma

0.00

0.39

0.0

1.0

—

580.64

—

Chronic rhinitis, nasopharyngitis and pharyngitis

797

1.10

0.39

1.0

823.84

723.18

ng/l

1.06

543

Peritonsillar abscess

421

0.85

0.39

1.0

932.00

727.27

ng/l

1.09

299

Nonalcoholic fatty liver disease

226

0.80

0.39

1.0

911.55

776.47

ng/l

0.60

154

Pilonidal cyst

115

1.31

0.38

1.0

1139.25

787.18

ng/l

—

Other disorders of breast

242

1.20

0.38

1.1

1.0

993.86

755.04

ng/l

1.63

168

Pregnancy, childbirth and the puerperium

276

1.14

0.38

1.0

690.20

703.76

ng/l

0.07

169

Other (seronegative) rheumatoid arthritis, wide

474

0.86

0.38

1.0

728.16

721.00

ng/l

0.04

317

Other inflammation of eyelid

307

1.17

0.38

1.0

941.92

695.50

ng/l

1.79

200

Pregnancy hypertension

718

0.90

0.38

1.1

1.0

708.54

763.31

ng/l

0.47

516

Crohn disease

261

1.19

0.38

1.0

845.50

754.96

ng/l

0.65

180

Viral haemorrhagic fevers, not elsewhere classified/unspecified

181

0.77

0.38

1.1

1.0

658.67

741.64

ng/l

—

121

Benign lipomatous neoplasm

799

1.10

0.38

1.0

831.65

726.71

ng/l

1.06

544

Impacted cerumen

252

1.19

0.37

1.0

736.65

668.77

ng/l

0.34

163

Purpura and other haemorrhagic conditions

301

0.83

0.37

1.0

722.85

716.64

ng/l

0.02

194

Anomalies of dental arch relationship, including avohilmo

291

0.84

0.37

1.0

927.50

774.45

ng/l

0.64

200

Injury of eye and orbit

280

1.18

0.37

1.0

788.48

750.07

ng/l

0.19

194

Coxarthrosis [arthrosis of hip](FG)

206

1362

1.06

0.37

1.0

760.34

718.18

ng/l

0.72

131

935

Traumatic amputation of wrist and hand

107

1.31

0.37

1.0

1011.78

679.48

ng/l

—

Ulcerative rectosigmoiditis

170

1.24

0.37

1.0

798.38

757.88

ng/l

0.25

114

Glucosamine medication

169

1260

1.07

0.37

1.0

734.30

709.47

ng/l

0.28

107

848

Infections with a predominantly sexual mode of transmission

467

1.13

0.37

1.0

900.52

757.80

ng/l

1.07

325

Herpesviral [herpes simplex] infections

493

0.87

0.37

1.0

927.54

738.12

ng/l

1.27

339

Other and unspecified injuries of lower leg

134

1.27

0.36

1.1

1.0

627.09

697.54

ng/l

0.31

Asthma-related pneumonia

905

1.09

0.36

1.0

825.82

704.12

ng/l

1.37

586

Diabetic maculopathy, excluding more controls

235

1.19

0.36

1.0

755.63

767.78

ng/l

0.04

156

Diseases of arteries, arterioles and capillaries (FINNGEN)

531

0.90

0.36

1.0

727.89

716.35

ng/l

0.08

388

Malignant neoplasm of other and unspecified female genital organs, including Hilmo

0.63

0.35

1.0

683.60

709.55

ng/l

—

Pleural plaque with presence of asbestos

201

0.79

0.35

1.0

504.27

625.54

ng/l

0.59

123

Combinations of oral blood glucose lowering drugs

889

1.09

0.35

1.1

1.0

730.72

728.24

ng/l

0.02

603

Fenamates

222

1.16

0.35

1.0

669.72

722.87

ng/l

0.36

149

Other disorders of skin and subcutaneous tissue

218

1829

1.06

0.35

1.0

808.85

722.20

ng/l

1.69

143

1240

Endometriosis ASRM stages 3,4

413

1.14

0.35

1.0

704.00

726.39

ng/l

0.14

284

Major coronary heart disease event excluding revascularizations

202

1428

0.94

0.35

1.0

676.52

728.97

ng/l

1.10

128

977

Other disorders of bone density and structure

1.40

0.35

1.2

1.0

939.17

687.93

ng/l

—

Asthma/COPD (KELA code 203)

285

1858

1.05

0.35

1.0

781.57

737.69

ng/l

0.88

195

1271

Triptan medication for migraine, min. 3 purchases

109

902

0.92

0.35

1.0

783.77

763.75

ng/l

0.16

661

Other symptoms and signs involving the digestive system and abdomen

395

1.14

0.34

1.0

815.26

690.62

ng/l

1.10

255

Presence of cardiac and vascular implants and grafts

137

1093

0.93

0.34

1.0

700.65

710.83

ng/l

0.10

700

Acute appendicitis

179

1778

0.94

0.34

1.1

1.0

831.03

750.56

ng/l

1.32

138

1239

Pain and other conditions associated with female genital organs and menstrual cycle

294

1.16

0.34

1.1

1.0

730.00

747.07

ng/l

0.09

206

Other disorders of prostate

1.34

0.34

1.0

1146.67

668.45

ng/l

—

Varicose veins of other sites

154

1.24

0.34

1.0

585.64

717.66

ng/l

0.77

103

Allergic purpura

1.33

0.33

1.0

1113.33

610.67

ng/l

—

Retinal vascular occlusion

302

1.16

0.33

1.0

701.35

696.54

ng/l

0.02

182

Other disorders of optic [2nd] nerve and visual pathways

127

1.26

0.33

1.0

799.09

700.89

ng/l

0.29

Other acute lower respiratory infections

117

1201

0.93

0.33

1.0

712.89

731.80

ng/l

0.18

805

Asthma, hospital admissions 3, pneumonia

910

1.09

0.33

1.0

825.82

703.87

ng/l

1.38

588

Asthma-related pneumonia or sepsis

910

1.09

0.33

1.0

825.82

703.87

ng/l

1.38

588

Vitamin B12 deficiency anaemia

256

1.17

0.33

1.1

1.0

684.26

663.90

ng/l

0.10

155

Lichen ruber planus, wide definition including periferal and oral lichen planus

596

1.11

0.33

1.0

820.13

725.60

ng/l

0.83

411

Ectopic pregnancy

371

0.86

0.33

1.1

1.0

783.85

765.58

ng/l

0.07

275

Single spontaneous delivery

456

1.09

0.32

1.0

728.29

734.42

ng/l

0.04

304

Congenital malformations of heart and great arteries

224

0.82

0.32

1.0

818.29

737.30

ng/l

0.28

149

Obstructed labour due to malposition and malpresentation of fetus

265

1.16

0.32

1.0

663.41

816.24

ng/l

1.57

201

Complications predominantly related to the puerperium

435

1.13

0.32

1.0

854.46

743.32

ng/l

0.98

314

Other and unspecified visual disturbances

238

1.18

0.32

1.0

905.89

717.56

ng/l

1.35

154

Convergent concomitant strabismus

1.35

0.32

1.0

800.40

768.31

ng/l

—

Other female pelvic inflammatory diseases

341

1.14

0.32

1.0

746.39

721.97

ng/l

0.15

229

Superficial injury of ankle and foot

198

0.81

0.32

1.1

1.0

814.50

768.15

ng/l

—

131

Other arrhythmias

193

1540

0.94

0.32

1.0

779.35

752.64

ng/l

0.33

127

1073

Delivery, wide proxy

336

1.11

0.32

1.0

717.93

720.06

ng/l

0.01

208

Glaucoma-related operations

128

1.25

0.32

1.0

842.30

641.04

ng/l

—

Other diseases of intestine

398

1.13

0.32

1.0

671.75

710.40

ng/l

0.31

263

Atopic dermatitis

136

1041

1.07

0.31

1.0

863.58

743.58

ng/l

2.22

102

731

Chalazion

248

1.17

0.31

1.1

1.0

757.81

732.49

ng/l

0.11

167

Other heart diseases, wide

282

1645

1.05

0.31

1.0

770.43

756.83

ng/l

0.19

193

1155

Asthma, hospital admission 2, infections

157

1445

1.06

0.31

1.0

821.63

718.98

ng/l

1.67

101

963

Asthma-related infections

157

1445

1.06

0.31

1.0

821.63

718.98

ng/l

1.67

101

963

Thyroiditis, ILD-related definition

211

1.19

0.31

1.0

891.79

720.97

ng/l

0.75

147

Other metabolic disorders

267

1.16

0.31

1.0

781.35

752.38

ng/l

0.12

177

Atopic dermatitis, strict definition with reimbursement

449

1.12

0.31

1.1

1.0

880.73

746.17

ng/l

1.36

320

Azathioprine

314

1.15

0.31

1.0

765.29

752.56

ng/l

0.06

218

Delivery

456

1.09

0.31

1.0

724.92

734.42

ng/l

0.07

304

Benign neoplasm: Tongue

1.32

0.31

1.1

1.0

849.86

635.73

ng/l

—

Short Achilles tendon (acquired)

1.32

0.31

1.3

1.0

481.43

672.73

ng/l

—

Diseases of the respiratory system

206

977

1.06

0.30

1.0

758.65

733.81

ng/l

0.30

137

661

Otitis externa

504

1.11

0.30

1.0

707.62

732.71

ng/l

0.18

346

Spirochaetal infections, other/unspecified

221

1.18

0.30

1.1

1.0

777.53

708.64

ng/l

0.23

146

Elevated blood glucose level

184

1.20

0.30

1.0

842.94

700.08

ng/l

0.73

114

Acute upper respiratory infections of multiple and unspecified sites

187

1464

0.95

0.30

1.0

790.26

744.76

ng/l

0.73

137

1003

Trigger finger

362

1.13

0.30

1.0

741.88

705.85

ng/l

0.25

252

Arthropathies

250

1206

1.05

0.30

1.0

790.98

723.76

ng/l

1.49

177

836

Conductive hearing loss, unspecified

175

1.20

0.30

1.0

844.00

702.99

ng/l

0.51

118

Lesion of ulnar nerve

353

1.13

0.30

1.0

838.19

747.55

ng/l

0.64

244

Benign neoplasm: Ascending colon

391

1.13

0.29

1.0

676.14

688.58

ng/l

0.07

260

Retinal vascular disorders

306

1.14

0.29

1.0

701.35

696.59

ng/l

0.02

184

Seronegative rheumatoid arthritis

303

0.86

0.29

1.0

738.12

694.62

ng/l

0.22

205

Excessive attrition of teeth

150

1413

1.06

0.29

1.0

781.74

749.25

ng/l

0.42

107

986

Other and unspecified dermatitis

150

1413

1.06

0.29

1.0

785.05

725.80

ng/l

0.84

958

Benign neoplasm of major salivary glands

260

0.85

0.29

1.0

980.14

707.00

ng/l

1.26

171

Other otitis externa (chronic)

139

1.22

0.29

1.0

838.56

702.76

ng/l

—

Other disorders of skin and subcutaneous tissue, not elsewhere classified

345

0.87

0.29

1.1

1.0

692.68

716.21

ng/l

0.11

230

Injuries involving multiple body regions

1.23

0.29

1.1

1.0

687.57

647.31

ng/l

—

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

241

1.16

0.29

1.0

795.52

762.79

ng/l

0.14

165

Care involving dialysis

184

0.81

0.28

1.0

708.90

715.03

ng/l

—

122

Squamous cell neoplasms and carcinomas of the skin

216

0.83

0.28

1.0

725.56

627.22

ng/l

—

124

Other shoulder lesions

195

1.18

0.28

1.0

869.00

692.32

ng/l

1.02

132

Hypertrophy of breast

336

1.13

0.28

1.0

798.38

743.51

ng/l

0.27

239

Phlebitis and thrombophlebitis (not including DVT)

595

0.91

0.27

1.0

810.61

719.85

ng/l

0.76

412

ILD medications: azathioprine

318

1.13

0.27

1.0

765.29

740.76

ng/l

0.12

216

Unspecified misadventure during surgical and medical care

131

1.22

0.27

1.0

798.00

686.35

ng/l

—

Benign neoplasm of ovary

404

1.11

0.26

1.0

820.47

712.15

ng/l

0.85

275

Obesity and other hyperalimentation

157

1596

0.95

0.26

1.0

883.42

739.13

ng/l

3.29

112

1107

Complications of labour and delivery

141

831

0.94

0.26

1.0

747.04

745.13

ng/l

0.02

588

Other skin changes

489

0.90

0.26

1.0

771.63

721.25

ng/l

0.41

326

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

357

1.12

0.26

1.0

765.33

763.10

ng/l

0.01

255

Dermatophytosis

175

1662

1.05

0.26

1.0

812.69

729.58

ng/l

1.33

113

1142

Other hearing loss

692

0.92

0.26

1.0

692.21

687.98

ng/l

0.02

443

Other arthritis (FG)

842

0.93

0.26

1.0

764.27

719.70

ng/l

0.37

565

Endometriosis of ovary

333

0.88

0.25

1.0

707.90

715.74

ng/l

0.04

224

LSIL lesion of the cervix uteri, vagina or vulva

188

1.17

0.25

1.0

579.79

776.02

ng/l

1.66

139

Spondyloarthritis

377

1.11

0.25

1.0

768.07

729.94

ng/l

0.16

263

Vascular disorders of the intestines

160

1.19

0.25

1.0

898.89

641.19

ng/l

—

Chronic sinusitis

120

1129

1.06

0.25

1.0

733.85

731.47

ng/l

0.02

774

Coeliac disease

254

1.14

0.25

1.0

827.91

718.47

ng/l

0.99

169

Benign neoplasm: Rectum, anus and anal canal

598

1.09

0.25

1.0

741.00

707.10

ng/l

0.27

386

Unspecified jaundice

105

1.24

0.24

1.0

870.86

635.65

ng/l

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

310

1913

1.04

0.24

1.0

776.70

741.45

ng/l

0.66

196

1335

Certain disorders involving the immune mechanism

464

1.10

0.24

1.0

830.90

728.52

ng/l

0.89

319

Endometriosis ASRM stages 1,2

283

1.13

0.24

1.0

700.42

748.67

ng/l

0.25

201

Coagulation defects, purpura and other haemorrhagic conditions

434

0.90

0.24

1.0

669.36

732.99

ng/l

0.34

291

Diabetic maculopathy

231

1.14

0.24

1.0

755.63

728.54

ng/l

0.10

163

Iron deficiency anaemia secondary to blood loss (chronic)

402

0.90

0.24

1.0

629.70

692.47

ng/l

0.52

257

Non-follicular lymphoma

265

0.87

0.24

1.0

754.94

698.11

ng/l

0.21

170

Other necrotizing vasculopathies

180

1.17

0.23

1.0

661.38

674.07

ng/l

0.06

111

Other/unspecified rheumatoid arthritis

307

0.88

0.23

1.0

680.24

701.20

ng/l

0.10

193

Plantar fascial fibromatosis

218

1.15

0.23

1.0

764.67

703.67

ng/l

0.25

142

Ulcerative colitis, NAS

296

0.88

0.23

1.0

800.85

750.08

ng/l

0.27

207

Cholecystitis

359

0.89

0.23

1.0

797.59

697.22

ng/l

0.36

238

Otitis media, unspecified

123

1.20

0.23

1.0

901.91

708.45

ng/l

0.66

Obesity

157

1589

0.95

0.23

1.0

883.42

739.52

ng/l

3.27

112

1105

Hypokalaemia

294

1.12

0.23

1.1

1.0

705.38

744.70

ng/l

0.25

191

Rash and other nonspecific skin eruption

211

0.85

0.23

1.1

1.0

717.77

712.58

ng/l

0.01

137

Disorders of gallbladder, biliary tract and pancreas

300

1958

0.97

0.23

1.0

760.58

744.44

ng/l

0.22

192

1354

Undetermined asthma, excluding more controls

327

0.89

0.23

1.0

711.77

678.15

ng/l

0.15

208

Undetermined asthma

327

0.89

0.23

1.0

711.77

677.51

ng/l

0.15

211

Benign neoplasm of other and ill-defined parts of digestive system

486

1.09

0.22

1.1

1.0

819.47

712.48

ng/l

1.02

325

Internal derangement of knee

111

1043

1.06

0.22

1.0

779.07

728.76

ng/l

0.62

724

Benign neoplasm: Vulva

1.25

0.22

1.0

795.00

690.96

ng/l

—

Calcific tendinitis of shoulder

125

1.20

0.22

1.0

696.50

673.80

ng/l

—

All dysplastic lesions of the cervix uteri

303

0.88

0.22

1.0

721.47

785.91

ng/l

0.29

223

Striking against or struck by other objects

698

1.07

0.22

1.0

834.89

753.49

ng/l

0.71

480

Disturbances of skin sensation

602

1.08

0.22

1.0

825.47

737.93

ng/l

0.76

418

Maternal care for known or suspected abnormality of pelvic organs

187

0.87

0.22

1.0

899.29

785.69

ng/l

0.51

140

Septicaemia

125

1108

1.06

0.22

1.0

687.46

709.53

ng/l

0.23

716

Diabetic nephropathy

338

1.11

0.22

1.0

846.57

722.00

ng/l

0.85

216

Thyrotoxicosis

597

0.92

0.22

1.0

603.89

726.69

ng/l

1.76

403

Other nonautoimmune haemolytic anaemias

0.00

0.21

0.0

1.0

—

413.67

—

Cytomegaloviral hepatitis

0.00

0.21

0.0

1.0

—

482.20

—

Benign neoplasm: Extrahepatic bile ducts

0.00

0.21

0.0

1.0

—

485.00

—

Fitting and adjustment of external prosthetic device

0.00

0.21

0.0

1.0

—

308.00

—

Pedestrian injured in collision with heavy transport vehicle or bus

0.00

0.21

0.0

1.0

—

449.83

—

Crushing injury of ankle and foot

0.00

0.21

0.0

1.0

—

478.00

—

Pneumonia due to Haemophilus influenzae

0.00

0.21

0.0

1.0

—

452.60

—

Lupus nephritis

0.00

0.21

0.0

1.0

—

630.80

—

Drowning and submersion while in natural water

0.00

0.21

0.0

1.0

—

422.83

—

Systemic sclerosis, icd10

1.19

0.21

1.0

1115.00

676.33

ng/l

—

Listeriosis

0.00

0.21

0.0

1.0

—

486.60

—

Alcoholic cardiomyopathy

0.00

0.21

0.0

1.0

—

491.20

—

Acquired clawhand, clubhand, clawfoot and clubfoot

0.00

0.21

0.0

1.0

—

485.33

—

Other congenital malformations of urinary system

0.00

0.21

0.0

1.0

—

506.20

—

Occupant of pick-up truck or van injured in other and unspecified transport accidents

0.00

0.21

0.0

1.0

—

601.00

—

Pre-eclampsia

336

0.89

0.21

1.1

1.0

619.35

764.34

ng/l

1.16

243

Juvenile Open Angle Glaucoma

0.00

0.21

0.0

1.0

—

482.20

—

Other specified transport accidents

0.00

0.21

0.0

1.0

—

476.60

—

Other superficial injuries of ankle and foot

0.00

0.21

0.0

1.0

—

454.17

—

Clubfoot

0.00

0.21

0.0

1.0

—

497.60

—

Benign neoplasm: Ciliary body

0.00

0.21

0.0

1.0

—

503.33

—

Other mycoses, not elsewhere classified/unspecified

0.00

0.21

0.0

1.0

—

527.67

—

Abnormal findings in peritoneal fluid saliva

0.00

0.21

0.0

1.0

—

541.57

—

Allergic bronchopulmonary aspergillosis (ABPA)

0.00

0.21

0.0

1.0

—

535.40

—

Nezelof syndrome

0.00

0.21

0.0

1.0

—

532.43

—

Congenital cataract

0.00

0.21

0.0

1.0

—

452.71

—

Congenital malformations of oesophagus

0.00

0.21

0.0

1.0

—

608.33

—

Renal agenesis and other reduction defects of kidney

0.00

0.21

0.0

1.0

—

501.33

—

Other dermatomyositis

0.00

0.21

0.0

1.0

—

452.71

—

Severe visual impairment, binocular

0.00

0.21

0.0

1.0

—

483.83

—

Major coronary heart disease event

300

1751

1.03

0.21

1.0

755.13

745.62

ng/l

0.13

190

1228

Inhalation and ingestion of other objects causing obstruction of respiratory tract

0.00

0.21

0.0

1.0

—

549.57

—

Dacryoadenitis

0.00

0.21

0.0

1.0

—

480.14

—

Mandibular prognathia AND surgery (LeFortI or BSSO), including avohilmo

0.00

0.21

0.0

1.0

—

561.14

—

Other specified congenital malformation syndromes affecting multiple systems

0.00

0.21

0.0

1.0

—

650.83

—

Enterobiasis

0.00

0.21

0.0

1.0

—

576.71

—

Attention to artificial openings

1.23

0.21

1.0

549.00

617.72

ng/l

—

Macular pucker

471

0.91

0.21

1.0

738.55

685.14

ng/l

0.42

303

Bacterial pneumonia (organism specified)

113

1081

0.95

0.21

1.0

742.37

718.97

ng/l

0.23

710

Other spirochaetal diseases

837

1.06

0.21

1.0

744.00

727.55

ng/l

0.13

568

Left side

0.00

0.21

0.0

1.0

—

504.00

—

0.00

0.21

0.0

1.0

—

451.75

—

Other/unspecified mastoiditis and related conditions

0.00

0.21

0.0

1.0

—

506.20

—

ILD and respiratory illness in diseases classified elsewhere

0.00

0.21

0.0

1.0

—

451.75

—

Renal agenesis and other reduction defects of kidney

0.00

0.21

0.0

1.0

—

493.29

—

Hydrocephalus in other diseases

0.00

0.21

0.0

1.0

—

494.00

—

Burn and corrosion, body region unspecified

0.00

0.21

0.0

1.0

—

564.57

—

Benign neoplasm: Connective and other soft tissue of trunk, unspecified

0.00

0.21

0.0

1.0

—

558.83

—

Drug-induced systemic lupus erythematosus

0.00

0.21

0.0

1.0

—

482.86

—

Acute inflammation of orbit

0.00

0.21

0.0

1.0

—

454.29

—

Acute myringitis

0.00

0.21

0.0

1.0

—

559.14

—

Benign neoplasm: Bone and articular cartilage, unspecified

0.00

0.21

0.0

1.0

—

520.38

—

Mesial bite

0.00

0.21

0.0

1.0

—

523.25

—

Animal-rider or occupant of animal-drawn vehicle injured in transport accident

0.00

0.21

0.0

1.0

—

460.50

—

Other or ill-defined heart diseases

134

0.82

0.20

1.0

776.33

664.20

ng/l

—

Other and unspecified iron deficiency

862

0.94

0.20

1.0

711.41

714.73

ng/l

0.02

560

Rheumatoid lung disease

0.00

0.20

0.0

1.0

—

549.89

—

Carcinoma in situ of endometrium

0.00

0.20

0.0

1.0

—

626.00

—

Blindness or visual impairment, binocular

0.00

0.20

0.0

1.0

—

451.75

—

Benign neoplasm of soft tissue of retroperitoneum and peritoneum

0.00

0.20

0.0

1.0

—

515.89

—

Benign neoplasm: Retina

0.00

0.20

0.0

1.0

—

444.56

—

Reiter disease

0.00

0.20

0.0

1.0

—

505.71

—

Exposure to other and unspecified forces of nature

0.00

0.20

0.0

1.0

—

552.44

—

Serous carcinoma of ovary

0.00

0.20

0.0

1.0

—

691.86

—

Carcinoma in situ of breast, lobular

0.00

0.20

0.0

1.0

—

677.11

—

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

1.25

0.20

1.0

660.00

892.90

ng/l

—

Primary coxarthrosis, bilateral

872

0.94

0.20

1.0

762.23

700.98

ng/l

0.67

564

Stenosis and insufficiency of lacrimal passages

202

1.14

0.20

1.1

1.0

649.42

695.55

ng/l

0.21

129

HSIL lesion of the cervix uteri, vagina or vulva

229

0.87

0.20

1.0

955.71

764.94

ng/l

0.80

168

Other disorders of iris and ciliary body

1.20

0.19

1.0

877.00

633.34

ng/l

—

Codeine or tramadol medication

343

1822

1.03

0.19

1.0

806.61

723.63

ng/l

2.93

234

1240

Acne

1.20

0.19

1.2

1.0

880.33

797.60

ng/l

—

Spirochaetal infections, other/unspecified

830

1.06

0.19

1.0

735.33

729.46

ng/l

0.04

565

Congenital malformations, deformations and chromosomal abnormalities

132

1199

1.05

0.19

1.0

810.26

746.32

ng/l

0.87

838

Vestibular neuronitis

231

1.13

0.19

1.0

783.71

716.65

ng/l

0.23

148

Diabetic retinopathy, strict definition

305

1.10

0.19

1.0

833.28

739.97

ng/l

0.47

210

Unspecified acute lower respiratory infection

327

1.10

0.19

1.0

816.21

751.31

ng/l

0.30

221

Degeneration of macula and posterior pole

143

1189

0.96

0.19

1.0

704.72

697.23

ng/l

0.07

754

Other peripheral vertigo

228

0.88

0.19

1.1

1.0

717.21

708.61

ng/l

0.03

145

Thyrotoxicosis, other and/or unspecified

457

0.92

0.18

1.0

605.97

724.33

ng/l

1.32

322

Artrosis, including avohilmo

257

1362

1.03

0.18

1.0

776.84

724.72

ng/l

1.12

178

955

Nontoxic goitre/thyroid nodule

796

0.94

0.18

1.0

702.13

697.49

ng/l

0.04

529

Contact with machinery

300

0.90

0.18

1.0

803.11

714.98

ng/l

0.71

209

Retinal breaks without detachment

464

1.08

0.17

1.0

683.19

729.61

ng/l

0.33

309

Chronic laryngitis and laryngotracheitis

377

1.09

0.17

1.0

832.03

719.34

ng/l

0.94

260

Other anaemias

117

1164

0.95

0.17

1.0

734.56

707.27

ng/l

0.23

739

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

331

0.91

0.17

1.0

848.44

736.38

ng/l

0.72

220

Calculus of kidney and ureter

836

0.94

0.17

1.0

761.22

736.57

ng/l

0.21

566

All chronic kidney diseases

149

1268

0.96

0.17

1.0

736.09

718.53

ng/l

0.19

107

823

Pediculosis, acariasis and other infestations

281

1.10

0.17

1.1

1.0

874.21

780.40

ng/l

0.41

189

Pregnancy with abortive outcome

146

794

0.96

0.17

1.0

694.66

729.12

ng/l

0.47

552

Viral infections characterized by skin and mucous membrane lesions

233

2054

0.97

0.17

1.0

792.48

743.19

ng/l

0.85

153

1419

Other disorders of patella

372

0.91

0.17

1.0

801.12

718.89

ng/l

0.41

265

Ulcerative colitis

552

1.07

0.17

1.0

841.86

735.92

ng/l

1.11

378

Benign leiomyoma with endometriosis

368

1.09

0.17

1.0

683.60

712.24

ng/l

0.15

243

Ptosis of eyelid

291

1.10

0.17

1.1

1.0

723.50

675.57

ng/l

0.17

188

Zoster [herpes zoster]

142

1454

0.96

0.17

1.0

760.29

713.73

ng/l

0.66

970

Disorders of calcium metabolism

148

1.15

0.17

1.0

890.45

709.04

ng/l

0.61

Excessive, frequent and irregular menstruation

430

1.06

0.16

1.0

843.15

723.12

ng/l

1.16

288

Other disorders of kidney and ureter

340

1.09

0.16

1.0

872.26

708.90

ng/l

1.44

222

Oral corticosteroids

322

1862

1.03

0.16

1.0

800.09

736.52

ng/l

1.72

224

1277

Carcinoma in situ of breast, intraductal

214

0.89

0.15

1.0

759.86

724.42

ng/l

0.11

145

Thiazolidinediones

341

1.09

0.15

1.1

1.0

662.62

723.15

ng/l

0.54

223

Zoster [herpes zoster]

467

1.07

0.15

1.1

1.0

770.38

702.71

ng/l

0.46

307

Visual field defects

193

0.88

0.15

1.1

1.0

741.55

693.35

ng/l

0.12

123

Lichen sclerosus et atrophicus

235

1.11

0.15

1.0

899.40

720.90

ng/l

0.98

155

Perforation of tympanic membrane

216

1.11

0.15

1.0

727.50

688.86

ng/l

0.18

139

Rosacea

245

1.10

0.15

1.0

645.89

726.67

ng/l

0.44

165

Other and unspecified anaemias

117

1161

0.96

0.15

1.0

734.56

707.94

ng/l

0.22

737

Presence of other functional implants

196

1402

0.97

0.15

1.0

714.42

722.65

ng/l

0.09

138

928

Chronic nephritic syndrome

1.11

0.15

1.2

1.0

471.22

598.40

ng/l

—

Calculus of lower urinary tract

129

0.85

0.14

1.0

723.80

609.21

ng/l

—

Lichen planus

352

1.08

0.14

1.1

1.0

923.74

710.75

ng/l

1.76

232

Chondropathies

323

1.08

0.14

1.0

779.88

756.24

ng/l

0.13

226

Coxarthrosis, primary

196

1709

0.97

0.14

1.0

742.37

723.98

ng/l

0.25

119

1153

Other bacterial intestinal infections

430

1.07

0.14

1.0

750.97

720.51

ng/l

0.20

279

Postprocedural endocrine and metabolic disorders, not elsewhere classified

246

1.10

0.14

1.0

758.26

747.62

ng/l

0.04

162

Other specified/unspecified arthritis

727

0.95

0.14

1.0

752.17

718.50

ng/l

0.24

489

Other benign neoplasms of skin

1033

0.96

0.14

1.0

663.68

724.50

ng/l

0.75

695

Vitreous haemorrhage

254

0.90

0.14

1.0

712.81

697.75

ng/l

0.06

167

Chronic pancreatitis

347

0.92

0.14

1.0

836.17

709.24

ng/l

0.69

242

Other viral diseases, not elsewhere classified

342

1.08

0.14

1.0

821.81

770.47

ng/l

0.26

233

Congenital malformations, deformations and chromosomal abnormalities

151

1345

1.03

0.14

1.0

805.99

745.44

ng/l

0.85

104

929

Atrial fibrillation and flutter

100

621

1.04

0.14

1.0

770.21

733.47

ng/l

0.34

457

Disorders of mineral metabolism

208

1.11

0.14

1.0

905.80

732.71

ng/l

0.75

133

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

172

1750

0.97

0.14

1.0

802.52

726.52

ng/l

1.29

118

1178

Rheumatoid arthritis

843

0.96

0.13

1.0

813.16

706.57

ng/l

1.24

567

All dysplastic lesions of the cervix uteri, vagina or vulva

402

0.93

0.13

1.0

787.15

767.99

ng/l

0.08

291

Injury of other and unspecified intrathoracic organs

149

0.87

0.13

1.0

764.13

654.95

ng/l

—

Non-allergic asthma

189

1.11

0.13

1.0

801.44

712.68

ng/l

0.40

117

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

170

1.12

0.13

1.0

807.60

714.73

ng/l

—

108

Other complications of surgical and medical care, not elsewhere classified

228

1.10

0.13

1.0

863.15

689.35

ng/l

0.96

143

Pedal cyclist injured in noncollision transport accidents

238

1.09

0.13

1.0

664.95

756.27

ng/l

0.60

153

Other or unspecified ileus, impaction or obstruction

481

1.06

0.13

1.0

666.07

694.03

ng/l

0.16

317

Other diseases of arteries and capillaries

221

0.90

0.12

1.0

758.00

675.71

ng/l

0.31

138

Diabetes mellitus in pregnancy

175

0.91

0.12

1.0

818.53

820.54

ng/l

0.01

138

Infections with a predominantly sexual mode of transmission

540

1.05

0.12

1.0

892.06

755.21

ng/l

1.22

375

Pre-eclampsia or poor fetal growth

435

0.94

0.12

1.0

711.47

761.38

ng/l

0.30

313

Endometriosis of pelvic peritoneum

283

1.08

0.12

1.0

700.42

736.26

ng/l

0.17

195

Autoimmune diseases related-to ILD

234

2048

0.98

0.12

1.0

798.24

740.69

ng/l

1.03

153

1416

Unspecified kidney failure

239

1.09

0.12

1.0

728.26

663.72

ng/l

0.34

148

Scabies

210

1.10

0.12

1.1

1.0

791.65

807.06

ng/l

0.06

138

Nontoxic multinodular goitre

518

0.95

0.12

1.0

661.96

696.26

ng/l

0.32

347

Lyme disease

826

1.04

0.12

1.0

739.18

727.30

ng/l

0.09

562

Obesity due to excess calories

120

1161

1.03

0.12

1.0

884.27

732.79

ng/l

2.74

806

Cholesteatoma of middle ear

116

0.86

0.12

1.1

1.0

688.20

633.92

ng/l

—

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

317

1.07

0.12

1.0

752.87

764.99

ng/l

0.06

221

Persons encountering health services in circumstances related to reproduction

146

1013

0.97

0.11

1.0

793.89

778.81

ng/l

0.12

746

Dislocation, sprain and strain of joints and ligaments of knee

152

1441

0.97

0.11

1.0

777.86

753.54

ng/l

0.27

109

1016

Explicit bacterial Sepsis

168

0.89

0.11

1.0

588.40

643.12

ng/l

—

Disorders of vitreous body and globe

172

1608

1.03

0.11

1.0

726.34

727.88

ng/l

0.01

114

1099

Haemangioma and lymphangioma, any site

199

0.90

0.11

1.0

616.00

707.01

ng/l

0.46

126

Benign neoplasm: salivary glands, exclude unknown (D119)

230

0.91

0.11

1.0

944.54

724.56

ng/l

0.89

149

Salpingitis and oophoritis

425

0.94

0.11

1.1

1.0

788.35

735.64

ng/l

0.23

297

Secondary and unspecified malignant neoplasm of lymph nodes

240

0.92

0.11

1.0

1032.63

702.76

ng/l

2.39

148

Adverse effects, not elsewhere classified

386

1.06

0.11

1.0

726.12

735.50

ng/l

0.06

262

Dermatitis

178

1729

1.03

0.11

1.0

786.56

732.38

ng/l

0.86

117

1178

Glomerular disorders in diseases classified elsewhere

281

0.92

0.11

1.0

753.80

722.16

ng/l

0.16

188

Neoplasms

207

1071

1.02

0.11

1.0

800.88

754.60

ng/l

0.69

147

727

Percutaneous Coronary Intervention

277

1664

1.02

0.11

1.0

763.29

748.15

ng/l

0.21

168

1167

5-aminosalicylic acid

465

1.05

0.10

1.0

794.71

728.73

ng/l

0.54

320

102

978

1.03

0.10

1.0

796.14

719.92

ng/l

0.81

659

Vasomotor rhinitis (mode)

163

1.10

0.10

1.0

826.09

703.10

ng/l

0.60

107

Ethmoidectomy

311

0.93

0.10

1.0

773.35

742.33

ng/l

0.13

214

Other nutritional deficiencies

170

1640

0.98

0.10

1.0

898.02

734.93

ng/l

4.54

120

1138

Disorders of optic nerve and visual pathways

173

1.10

0.10

1.0

864.21

719.75

ng/l

0.48

109

Other diseases of blood and blood-forming organs

177

0.90

0.10

1.0

726.40

709.20

ng/l

—

109

Any death

213

1558

0.98

0.10

1.0

589.11

742.62

ng/l

6.95

145

1042

Other embolism and thrombosis

329

1.06

0.10

1.1

1.0

772.68

717.70

ng/l

0.28

220

Deep bite

146

0.90

0.10

1.0

1145.14

759.18

ng/l

—

Inguinal hernia, bilateral

290

1.07

0.10

1.0

590.53

704.04

ng/l

0.61

187

Osteonecrosis

154

1.10

0.10

1.0

863.30

700.73

ng/l

—

Retained placenta and membranes, without haemorrhage

228

0.92

0.10

1.1

1.0

900.07

747.90

ng/l

0.74

161

Systemic sclerosis (FG)

1.11

0.10

1.0

1115.00

608.50

ng/l

—

Reactive arthropathies

197

0.91

0.09

1.0

620.77

707.06

ng/l

0.43

138

Blepharochalasis

890

1.03

0.09

1.0

678.87

701.81

ng/l

0.21

585

Systemic sclerosis

1.09

0.09

1.0

1115.00

686.78

ng/l

—

Infective dermatitis

279

0.93

0.09

1.0

782.71

708.66

ng/l

0.46

187

Coronary atherosclerosis

240

1489

1.02

0.09

1.0

730.93

736.28

ng/l

0.06

158

1028

Diseases of salivary glands

798

0.96

0.09

1.0

766.35

725.87

ng/l

0.28

548

Aggressive periodontitis

1.04

0.09

1.2

1.0

796.80

616.73

ng/l

—

Benign lipomatous neoplasm of other sites/unspecified

217

0.92

0.09

1.0

739.09

689.48

ng/l

0.19

137

Viral infections characterized by skin and mucous membrane lesions

102

1049

0.97

0.09

1.0

798.55

733.54

ng/l

0.74

710

Other spirochaetal diseases

833

1.03

0.09

1.0

739.18

727.59

ng/l

0.08

566

Gestational [pregnancy-induced] hypertension

340

1.06

0.08

1.1

1.0

773.11

773.56

ng/l

0.00

247

Other specified/unspecified hearing loss

204

1.08

0.08

1.1

1.0

709.31

689.11

ng/l

0.06

129

Symptoms and signs involving the skin and subcutaneous tissue

194

1935

0.98

0.08

1.0

769.37

733.73

ng/l

0.50

136

1314

Artificial joint operation, meniscal resection

298

1964

0.98

0.08

1.0

776.56

742.17

ng/l

0.61

205

1347

Other and unspecified disease of Bartholin gland

1.03

0.08

1.0

937.67

724.32

ng/l

—

Pacemaker

903

1.03

0.08

1.0

711.30

693.89

ng/l

0.15

562

Benign neoplasm of mouth and pharynx

263

1.07

0.08

1.1

1.0

786.55

712.11

ng/l

0.43

171

Other/unspecified synovitis and tenosynovitis

263

1.06

0.08

1.0

737.27

707.45

ng/l

0.16

181

Necrosis of pulp, including avohilmo

152

1483

1.02

0.08

1.0

760.97

765.12

ng/l

0.04

114

1036

Disorders of vitreous body

167

1580

1.02

0.08

1.0

721.20

726.27

ng/l

0.05

113

1082

Inguinal or femoral hernia, bilateral

293

1.06

0.08

1.0

590.53

708.34

ng/l

0.64

188

LSIL lesion of the cervix uteri

127

1.10

0.07

1.0

551.11

822.48

ng/l

—

Use of rasagiline

0.82

0.07

1.2

1.0

886.67

631.12

ng/l

—

Other and unspecified disorders of vitreous body

142

1371

1.02

0.07

1.0

729.32

730.36

ng/l

0.01

934

Ulcerative colitis (strict definition, all Crohn cases excluded)

284

1.06

0.07

1.0

732.47

762.10

ng/l

0.15

193

Medical abortion

143

792

0.98

0.07

1.0

735.98

729.12

ng/l

0.07

552

Other maternal disorders predominantly related to pregnancy

124

795

0.98

0.07

1.0

786.38

753.14

ng/l

0.32

578

Postmenopausal atrophic vaginitis

421

0.97

0.07

1.1

1.0

741.56

720.75

ng/l

0.15

284

Other disorders of eyelid

142

1325

1.02

0.07

1.0

729.51

713.43

ng/l

0.15

886

Inflammatory disease of uterus

204

0.93

0.07

1.0

687.57

772.51

ng/l

0.43

138

Acute pancreatitis (for exclusion)

539

0.96

0.07

1.0

882.74

723.55

ng/l

1.32

359

Urolithiasis

913

0.97

0.07

1.0

758.24

728.71

ng/l

0.28

614

Emergency coronary revascularization (for ACS)

299

1794

1.01

0.06

1.0

763.07

743.11

ng/l

0.30

180

1256

Embedded and impacted teeth

185

0.94

0.06

1.0

958.63

822.42

ng/l

0.59

124

Other abnormal uterine and vaginal bleeding

393

0.97

0.06

1.0

798.05

711.98

ng/l

0.67

259

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

138

1.09

0.06

1.1

1.0

842.11

721.64

ng/l

—

Contraceptive management

689

0.98

0.06

1.0

771.33

792.94

ng/l

0.15

525

Localized swelling, mass and lump of skin and subcutaneous tissue

851

0.98

0.06

1.0

740.90

731.20

ng/l

0.06

579

Dyspnoea

274

1999

1.01

0.06

1.0

787.23

742.20

ng/l

0.90

184

1374

Atrophic disorders of skin

325

0.95

0.06

1.0

899.47

725.63

ng/l

1.17

215

Other diseases of stomach and duodenum

158

1.08

0.06

1.0

596.08

713.46

ng/l

0.72

Benign neoplasm of bone and articular cartilage

162

0.93

0.06

1.0

761.30

730.43

ng/l

—

101

346

1768

1.01

0.06

1.0

785.66

729.19

ng/l

1.41

232

1210

Glomerulonephritis

223

0.94

0.06

1.1

1.0

588.23

732.27

ng/l

1.06

146

Spontaneous abortion

682

0.98

0.06

1.0

882.38

739.64

ng/l

2.29

495

Obesity, other/unspecified

749

0.97

0.06

1.0

919.67

745.89

ng/l

2.34

525

Coronary revascularization (ANGIO or CABG)

275

1664

1.01

0.05

1.0

761.24

748.15

ng/l

0.18

170

1167

Other/unspecified disorders of vestibular function

1.11

0.05

1.0

608.00

656.33

ng/l

—

Obesity related asthma

950

1.02

0.05

1.0

867.73

724.47

ng/l

2.05

647

Acute appendicitis, no complications

139

1406

0.98

0.05

1.1

1.0

867.63

750.89

ng/l

1.80

107

981

Acute pancreatitis

536

0.97

0.05

1.0

882.74

716.71

ng/l

1.40

368

Migraine, single triptan purchase ok & required. ICD-code if available is included

193

1324

0.99

0.05

1.0

792.81

750.52

ng/l

0.58

134

945

Triptan medication for migraine, single purchase ok

193

1324

0.99

0.05

1.0

792.81

750.52

ng/l

0.58

134

945

Tuberculosis, IBD comorbidity

159

1.07

0.05

1.1

1.0

802.90

654.63

ng/l

—

Malignant neoplasm of endocrine gland

171

0.94

0.05

1.0

875.09

723.72

ng/l

0.41

109

Superficial injury of shoulder and upper arm

238

1.05

0.05

1.0

657.18

723.49

ng/l

0.40

159

Fracture of foot, except ankle

515

1.03

0.05

1.1

1.0

792.28

742.96

ng/l

0.33

363

Ulcerative colitis (strict definition, require KELA)

327

1.04

0.05

1.0

752.87

764.48

ng/l

0.06

229

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

683

0.98

0.05

1.0

821.47

746.11

ng/l

0.68

492

Malignant neoplasm of thyroid gland, including Hilmo

181

0.94

0.05

1.0

875.09

721.46

ng/l

0.42

114

Artificial joint re-operation

191

0.94

0.04

1.1

1.0

802.42

678.06

ng/l

0.42

117

Pre-eclampsia or eclampsia

373

0.97

0.04

1.1

1.0

655.76

759.63

ng/l

0.73

269

Acute upper respiratory infections

303

1883

0.99

0.04

1.0

809.32

731.43

ng/l

2.15

215

1280

Disorders of muscles

221

0.95

0.04

1.0

758.75

726.35

ng/l

0.13

149

Other local infections of skin and subcutaneous tissue

229

1.05

0.04

1.0

828.93

723.18

ng/l

0.63

148

Gonarthrosis,primary

312

1905

1.01

0.04

1.0

773.00

739.38

ng/l

0.61

212

1317

Iron deficiency anaemia

109

1091

0.98

0.04

1.0

682.97

716.13

ng/l

0.35

716

Umbilical hernia

715

0.98

0.04

1.0

793.87

742.50

ng/l

0.56

494

Hernia of abdominal wall, postoperative

473

0.97

0.04

1.0

733.84

707.31

ng/l

0.19

362

False labour

192

1.04

0.04

1.0

828.75

802.39

ng/l

0.11

152

Sulfasalazine

785

1.02

0.04

1.0

784.73

722.01

ng/l

0.48

536

Foreign body or object entering through skin

119

0.92

0.04

1.1

1.0

809.27

738.62

ng/l

0.44

Other disorders of the genitourinary system

319

1.03

0.03

1.0

697.14

696.08

ng/l

0.00

206

Suppurative and unspecified otitis media

463

0.98

0.03

1.1

1.0

899.47

758.48

ng/l

1.22

313

Other diseases of pancreas

230

0.96

0.03

1.0

812.00

690.26

ng/l

0.56

154

Normotensive glaucoma

230

1.04

0.03

1.0

714.94

693.10

ng/l

0.06

145

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

163

1645

0.99

0.03

1.0

796.23

724.60

ng/l

1.15

111

1107

Diseases of peritoneum

250

0.96

0.03

1.0

931.18

702.94

ng/l

1.24

161

Tuberculosis, wide

161

1.06

0.03

1.1

1.0

802.90

643.47

ng/l

—

Duodenal ulcer

270

1.04

0.03

1.0

773.86

681.20

ng/l

0.50

162

Glomerular diseases

441

0.97

0.03

1.0

696.13

718.64

ng/l

0.14

298

Presbycusis

307

1.03

0.03

1.1

1.0

703.90

641.04

ng/l

0.27

180

Seborrhoeic keratosis

648

1.02

0.03

1.0

833.31

699.24

ng/l

1.61

432

Spermatocele

191

1.05

0.03

1.0

573.60

744.81

ng/l

1.63

122

Dental pulpitis, including avohilmo

250

1610

1.01

0.03

1.0

799.53

756.13

ng/l

0.84

174

1145

Benign neoplasm: Parotid gland

199

0.95

0.03

1.1

1.0

944.54

702.37

ng/l

1.01

127

Paroxysmal tachycardia

495

0.98

0.03

1.1

1.0

780.11

707.28

ng/l

0.58

363

Bacterial pneumoniae

112

975

1.01

0.03

1.0

746.88

723.61

ng/l

0.23

654

Methotrexate

370

1.03

0.03

1.0

768.15

721.43

ng/l

0.22

256

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

239

0.96

0.02

1.0

813.41

713.87

ng/l

0.42

152

Bacterial intestinal infections, IBD co-morbidities

440

1.02

0.02

1.0

745.03

711.54

ng/l

0.22

289

Injury of unspecified body region

148

0.95

0.02

1.0

621.11

691.34

ng/l

—

Inflammatory bowel disease treatment related agents

335

1863

1.01

0.02

1.0

783.00

736.52

ng/l

1.15

237

1277

Macular hole

162

1.05

0.02

1.0

744.36

714.57

ng/l

0.07

Acute sinusitis

122

1118

1.01

0.02

1.0

847.38

749.01

ng/l

1.54

768

Haemangioma, any site

188

0.96

0.02

1.0

616.00

705.58

ng/l

0.44

117

Entropion and trichiasis of eyelid

208

0.96

0.02

1.1

1.0

693.91

632.77

ng/l

0.17

120

Other blood glucose lowering drugs, excl. Insulins

471

1.02

0.02

1.0

715.23

721.86

ng/l

0.04

302

Suggestive for eosinophilic asthma

248

0.97

0.02

1.0

761.87

703.06

ng/l

0.17

163

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

113

1.06

0.01

1.2

1.0

754.86

749.45

ng/l

—

Foreign body on external eye

348

0.98

0.01

1.0

837.31

752.01

ng/l

0.50

246

Other disorders of conjunctiva

372

1.02

0.01

1.0

735.33

709.51

ng/l

0.14

243

Postmenopausal bleeding

422

1.01

0.01

1.0

703.29

720.11

ng/l

0.14

284

Nutritional anaemias

135

1292

1.01

0.01

1.0

686.84

713.57

ng/l

0.31

835

Bronchiectasis

227

0.97

0.01

1.0

785.63

673.78

ng/l

0.51

137

Leiomyoma of uterus

160

901

1.01

0.01

1.0

752.09

741.54

ng/l

0.11

116

625

Sequelae of external causes of morbidity and mortality

657

0.99

0.01

1.0

819.65

726.90

ng/l

0.70

438

Complications of internal orthopaedic prosthetic devices, implants and grafts

663

1.01

0.01

1.0

857.09

684.46

ng/l

1.81

428

Otosclerosis

186

0.97

0.00

1.0

496.50

722.37

ng/l

—

118

Other and unspecified rosacea

194

1.03

0.00

1.0

721.50

718.36

ng/l

0.01

128

Sequelae of injuries of lower limb

196

0.97

0.00

1.1

1.0

866.55

740.48

ng/l

0.57

125

Angina pectoris

204

1364

1.00

0.00

1.0

730.87

727.30

ng/l

0.04

137

932

Cutaneous abscess, furuncle and carbuncle

586

0.99

0.00

1.0

673.92

733.98

ng/l

0.54

404

Asthma, including avohilmo

344

1928

1.00

0.00

1.0

802.90

736.78

ng/l

1.69

230

1326

Benign neoplasm: Skin of eyelid, including canthus

406

1.01

0.00

1.1

1.0

683.79

722.26

ng/l

0.25

268

Follicular cysts of skin and subcutaneous tissue

436

1.01

0.00

1.0

848.69

749.85

ng/l

0.59

299

Menorrhagia

430

1.01

0.00

1.0

813.15

723.12

ng/l

0.97

288

Sicca syndrome [Sjögren]

198

1.01

0.00

1.0

784.57

709.54

ng/l

0.24

130

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

198

1.01

0.00

1.1

1.0

884.00

717.42

ng/l

1.15

125

Pedal cyclist injured in other and unspecified transport accidents

242

0.99

0.00

1.0

914.07

759.73

ng/l

0.74

160

Benign neoplasm: Caecum

302

0.99

0.00

1.1

1.0

681.53

691.94

ng/l

0.03

192

Melanocytic naevi of other and unspecified parts of face

111

0.99

0.00

1.0

678.40

696.40

ng/l

—

Acute suppurative otitis media

285

1.01

0.00

1.1

1.0

950.78

778.45

ng/l

0.98

186

Bacterial pneumonia, not elsewhere classified

105

920

1.00

0.00

1.0

732.64

721.62

ng/l

0.10

615

Hyperkalaemia

124

0.97

0.00

1.0

653.86

658.10

ng/l

—

Hallux valgus (acquired)

104

745

1.00

0.00

1.0

703.09

703.53

ng/l

0.00

507

conjunctival haemorrhage

194

0.98

0.00

1.0

773.43

676.43

ng/l

0.42

122

Other and unspecified local infections of skin and subcutaneous tissue

217

1.01

0.00

1.0

828.93

721.77

ng/l

0.63

141

Other coagulation defects

128

1.02

0.00

1.0

535.63

700.43

ng/l

—

Cysts of oral region, not elsewhere classified

132

0.98

0.00

1.0

769.25

699.44

ng/l

—

FESS (DNB20)

293

0.99

0.00

1.0

773.35

742.50

ng/l

0.13

200

Candidiasis

315

0.98

0.00

1.0

881.75

714.24

ng/l

0.95

202

Oral lichen planus, including avohilmo , including avohilmo

162

0.99

0.00

1.0

902.18

719.86

ng/l

0.65

111

Malignant neoplasm of thyroid gland

162

0.99

0.00

1.0

875.09

720.82

ng/l

0.42

102

Hallux rigidus

413

0.99

0.00

1.0

874.83

676.42

ng/l

1.37

275

Intestinal stricture

867

1.00

0.00

1.0

756.78

723.22

ng/l

0.28

579

Abrasion of teeth

918

1.00

0.00

1.0

750.22

739.27

ng/l

0.10

636

Arthropod-borne viral fevers and viral haemorrhagic fevers

435

0.99

0.00

1.0

727.40

720.86

ng/l

0.03

293

Viral haemorrhagic fevers, not elsewhere classified/unspecified

384

0.99

0.00

1.1

1.0

726.71

722.92

ng/l

0.02

260

Unspecified lump in breast

339

1.00

0.00

1.0

761.48

719.48

ng/l

0.20

231

Other and unspecified drugs and medicaments

186

1.02

0.00

1.1

1.0

886.92

693.27

ng/l

1.28

114

Familial hypercholesterolemia, with ischemic heart disease

264

0.98

0.00

1.0

647.11

666.62

ng/l

0.11

167

Sequelae with surgical and medical care as external cause

539

1.00

0.00

1.0

875.57

709.88

ng/l

1.28

358

Brain meningioma, including Hilmo

138

1.01

0.00

1.0

906.67

713.21

ng/l

—

Asthma and opportunity respiratory infection

113

0.97

0.00

1.0

1015.50

669.28

ng/l

—

Brain meningioma

133

0.98

0.00

1.0

972.88

715.82

ng/l

—

Dermatographic urticaria

113

0.97

0.00

1.0

972.33

732.92

ng/l

—

Fall on and from ladder

203

0.99

0.00

1.1

1.0

691.09

707.30

ng/l

0.04

133

Thyroiditis

133

0.98

0.00

1.0

1001.88

725.46

ng/l

—

Intestinal adhesions without obstruction

213

0.99

0.00

1.0

890.50

685.60

ng/l

1.21

141

Glaucoma, exfoliation

253

0.99

0.00

1.1

1.0

778.69

669.61

ng/l

0.48

155

Spontaneous rupture of synovium and tendon

220

1.00

0.00

1.0

604.85

716.42

ng/l

0.90

149

Other secondary coxarthrosis

1.01

0.00

1.0

1031.00

653.39

ng/l

—

Nontoxic single thyroid nodule

170

1.00

-0.00

1.0

693.58

733.38

ng/l

0.14

112

Sequelae of hyperalimentation

0.00

-0.00

0.0

1.0

—

393.60

—

Other disorders of adrenal gland

0.89

-0.00

1.0

795.29

672.78

ng/l

—

Hirsutism, drug-induced

0.00

-0.00

0.0

1.0

—

466.60

—

Acidosis

0.89

-0.00

1.2

1.0

679.40

661.84

ng/l

—

Other congenital malformations of circulatory system

1.00

-0.00

1.0

814.00

634.47

ng/l

—

Ependymoma

0.00

-0.00

0.0

1.0

—

527.00

—

Cyst of Bartholin Gland

0.95

-0.00

1.3

1.0

648.83

778.12

ng/l

—

Benign neoplasm: Skin of other and unspecified parts of face

250

1.00

-0.00

1.0

682.31

705.55

ng/l

0.09

163

Brain astrocytoma

0.00

-0.00

0.0

1.0

—

578.75

—

Brain astrocytoma, including Hilmo

0.00

-0.00

0.0

1.0

—

578.75

—

Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system

0.00

-0.00

0.0

1.0

—

491.83

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS